≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Lesion of sciatic nerve

DOID EFO Endpoint Browser PheWeb

G6_SCIALE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G57.0
  • Hospital discharge: ICD-9 — 3550
  • Hospital discharge: ICD-8 — 35399
  • Cause of death: ICD-10 — G57.0
  • Cause of death: ICD-9 — 3550
  • Cause of death: ICD-8 — 35399

2 out of 7 registries used, show all original rules.

1790

4. Check minimum number of events

None

1790

5. Include endpoints

None

1790

6. Filter based on genotype QC (FinnGen only)

1747

Control definitions (FinnGen only)

Control exclude
G6_NERPLEX

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G57
Name in latin
Morbositas nervi ischiadici

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 19701 9844 9570
Only index persons 13546 7540 6006
Unadjusted period prevalence (%)
Whole population 0.28 0.28 0.27
Only index persons 0.26 0.28 0.23
Median age at first event (years)
Whole population 45.13 45.57 44.49
Only index persons 41.89 43.07 40.41

-FinnGen-

Key figures

All Female Male
Number of individuals 1747 806 941
Unadjusted period prevalence (%) 0.36 0.29 0.43
Median age at first event (years) 41.33 40.16 42.33

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1790
Matched controls
17900
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
35399
ICD-8 Finland
Sciatica
+∞
307.7
1433
*
G57.0
ICD-10 Finland
Lesion of sciatic nerve
1261.3
307.7
313
*
72510
ICD-8 Finland
Displacement of intervertebral disk, Lumbalis cum prolapsu disci
18.3
307.7
382
262
G56.0
ICD-10 Finland
Carpal tunnel syndrome
15.9
279.1
252
183
72880
ICD-8 Finland
Vertebrogenic pain syndrome, Radicula syndrome of lower limbs
16.0
229.5
204
143
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
58.6
186.9
105
19
72870
ICD-8 Finland
Vertebrogenic pain syndrome, Lumbalgia
13.1
128.7
126
103
ACC51
NOMESCO Finland
Release of median nerve
153.0
121.9
128
9
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
4.0
109.0
364
1069
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
6.6
99.5
170
282
N03AX16
ATC
[U] pregabalin
3.1
95.8
549
2253
M48.0
ICD-10 Finland
Spinal stenosis
3.3
86.8
389
1373
N03AX12
ATC
[U] gabapentin; oral
3.3
83.5
385
1380
N02AX02
ATC
tramadol; systemic, rectal
2.6
81.5
941
5418
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
22.7
72.3
53
24
M54.4
ICD-10 Finland
Lumbago with sciatica
3.0
67.6
369
1444
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
19.8
64.3
50
26
9211
FHL
Exploration or removal of diskusprolapse
6.6
61.0
100
158
3550A
ICD-9 Finland
Mononeuritis of lower limb, Lesion of sciatic nerve
+∞
60.8
58
*
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
19.6
59.0
46
24
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.9
59.0
185
510
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
55.2
435
2030
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
4.1
55.0
163
431
XA402
NOMESCO Finland
ENMG
8.5
53.7
70
85
G56.2
ICD-10 Finland
Lesion of ulnar nerve
18.7
52.7
42
23
7228C
ICD-9 Finland
Intervertebral disk disorders, Postlaminectomy syndrome[SYNDROMA LUMBOSACRALE POSTLAMINECTOMIAM]
22.8
51.9
38
17
9212
FHL
Other posterior root decompression surgery (eg laminectomy, Gill)
10.1
47.3
54
55
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.2
45.8
479
2505
72899
ICD-8 Finland
Vertebrogenic pain syndrome, Other and unspecified
12.6
43.6
43
35
N06AX21
ATC
duloxetine; oral
2.8
41.7
224
856
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.9
41.4
215
806
N06AA09
ATC
amitriptyline; systemic
2.8
40.4
228
893
71312
ICD-8 Finland
Osteo-arthritis and allied conditions, Spondylarthritis lumbalis sive lumbosacralis
8.2
39.8
53
66
72898
ICD-8 Finland
Vertebrogenic pain syndrome, Alia definita
11.3
39.0
41
37
M54.5
ICD-10 Finland
Low back pain
1.9
35.3
605
3738
N02AC04
ATC
dextropropoxyphene; oral
3.3
35.3
139
443
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
4.5
35.1
87
200
N02BF01
ATC
gabapentin; oral
2.7
33.8
196
776
M54.3
ICD-10 Finland
Sciatica
3.2
30.8
131
437
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
10.8
30.5
33
31
M79.0
ICD-10 Finland
Rheumatism, unspecified
4.4
30.5
78
184
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.9
30.0
459
2706
A02BC03
ATC
lansoprazole; oral
1.8
30.0
579
3680
M47.9
ICD-10 Finland
Spondylosis, unspecified
4.2
29.6
81
201
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
29.6
569
3609
M01AE03
ATC
ketoprofen; systemic, rectal
1.8
28.9
700
4750
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
28.6
728
5009
7240B
ICD-9 Finland
Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]
7.6
27.6
39
52
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
27.5
608
4004
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.0
27.4
125
434
71700, ,
ICD-8 Finland
10.5
27.2
30
29
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
27.0
322
1733
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.4
26.6
195
861
M54.1
ICD-10 Finland
Radiculopathy
3.6
26.5
88
251
M70.6
ICD-10 Finland
Trochanteric bursitis
2.1
25.5
259
1311
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
5.9
25.5
46
80
M03BX02
ATC
tizanidine; oral
1.7
24.3
881
6581
G57.6
ICD-10 Finland
Lesion of plantar nerve
8.5
24.0
31
37
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.8
23.3
123
462
A02BC05
ATC
esomeprazole; systemic
1.7
22.9
689
4881
N02AA05
ATC
oxycodone; systemic
1.8
22.7
442
2778
L86
ICPC
Back syndrome with radiating pain
2.8
22.7
119
446
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.2
22.7
91
293
M01AB05
ATC
diclofenac; systemic, rectal
1.6
22.4
1031
8112
N02BF02
ATC
pregabalin; oral
2.7
22.2
122
468
7221A
ICD-9 Finland
Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy
7.4
22.1
32
44
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
2.8
22.1
113
418
M01AC06
ATC
meloxicam; systemic, rectal
1.7
21.9
603
4165
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
21.6
346
2046
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.4
21.6
162
722
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
21.4
615
4289
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.1
21.4
215
1081
M01AH02
ATC
rofecoxib; oral
2.0
21.2
266
1451
M79.6
ICD-10 Finland
Pain in limb
1.6
20.6
689
4981
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
25.8
20.5
28
11
A01
ICPC
Pain general/multiple sites
2.1
20.1
202
1014
R03AC02
ATC
salbutamol; inhalant
1.6
20.0
868
6659
L03
ICPC
Low back symptom/complaint
1.7
20.0
438
2833
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
3.1
20.0
87
294
3540A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome
+∞
19.8
19
*
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
2.4
19.7
146
647
G51.0
ICD-10 Finland
Bell palsy
29.3
19.7
26
9
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.7
19.6
63
176
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
3.2
19.5
79
256
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
19.3
511
3473
79199
ICD-8 Finland
Headache
4.5
19.2
47
107
C01DA14
ATC
isosorbide mononitrate; oral
1.7
19.1
455
3006
M47.82
ICD-10 Finland
Other spondylosis, cervical region
3.0
18.9
87
304
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.1
18.8
188
941
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
5.5
18.6
36
67
H02AB06
ATC
prednisolone; systemic
1.6
18.1
829
6389
M25.5
ICD-10 Finland
Pain in joint
1.7
18.1
461
3093
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
5.0
18.1
39
80
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
18.0
187
950
SPAT1153
SPAT
Removal of sutures
1.6
17.9
546
3829
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.9
17.9
238
1320
N03AF01
ATC
carbamazepine; oral, rectal
2.6
17.9
105
417
M01AX17
ATC
nimesulide; oral
1.7
17.8
442
2943
A06AD11
ATC
lactulose; oral
1.7
17.6
371
2366
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
2.2
17.5
157
753
N06AX16
ATC
venlafaxine; oral
2.0
17.4
190
983
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
17.3
145
676
G44.2
ICD-10 Finland
Tension-type headache
2.0
17.2
194
1015
72519
ICD-8 Finland
Displacement of intervertebral disk, Lumbalis et lumbosacralis NUD
14.9
17.1
28
19
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
17.1
369
2365
M01AE51
ATC
ibuprofen, combinations; systemic
4.2
17.1
46
113
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.9
17.0
257
1483
R52.2
ICD-10 Finland
Other chronic pain
3.1
17.0
70
229
N05BA01
ATC
diazepam; systemic, rectal
1.9
16.8
248
1421
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.9
16.8
234
1316
M02AA07
ATC
piroxicam; topical
1.6
16.8
643
4741
35708
ICD-8 Finland
Other diseases of peripheral nerves except autonomic, Alterius nervi
+∞
16.7
16
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
16.7
617
4511
R42
ICD-10 Finland
Dizziness and giddiness
1.6
16.7
461
3147
R51.80
ICD-10 Finland
Headache
1.9
16.6
215
1180
M54.6
ICD-10 Finland
Pain in thoracic spine
2.4
16.2
111
474
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
4.0
16.1
46
118
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.9
16.1
77
275
M01AH05
ATC
etoricoxib; oral
1.5
16.1
863
6823
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.8
16.0
288
1752
M01AB55
ATC
diclofenac, combinations; oral
2.1
15.9
152
747
M01AH01
ATC
celecoxib; oral
1.7
15.9
313
1952
ABD30
NOMESCO Finland
Implantation of spinal stimulation device
14.6
15.8
26
18
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.2
15.8
142
681
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
5.2
15.8
32
62
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
15.8
187
996
L01
ICPC
Neck symptom/complaint
1.8
15.7
238
1374
R06.0
ICD-10 Finland
Dyspnoea
1.6
15.6
525
3744
G54.0
ICD-10 Finland
Brachial plexus disorders
13.9
15.5
26
19
ACC53
NOMESCO Finland
Release of ulnar nerve
161.4
15.5
16
*
M79.7
ICD-10 Finland
Fibromyalgia
3.5
15.4
53
155
G57.8
ICD-10 Finland
Other mononeuropathies of lower limb
38.4
15.4
19
5
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
3.8
15.4
47
127
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
3.6
15.3
51
146
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
15.0
296
1846
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
14.8
511
3660
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
14.7
102
438
G57.1
ICD-10 Finland
Meralgia paraesthetica
6.2
14.7
25
41
M03BC51
ATC
orphenadrine, combinations; systemic
1.6
14.7
378
2527
M54.2
ICD-10 Finland
Cervicalgia
2.2
14.6
125
588
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.5
14.6
527
3809
G57.2
ICD-10 Finland
Lesion of femoral nerve
151.2
14.5
15
*
SPAT1301
SPAT
No procedures
1.5
14.4
556
4075
A02BC02
ATC
pantoprazole; systemic
1.5
14.2
1161
9887
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
14.2
274
1697
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.5
14.1
90
372
A02BC01
ATC
omeprazole; systemic
1.5
14.0
494
3547
SPAT1229
SPAT
Assessment of need for aid
1.9
13.8
173
939
R52.1
ICD-10 Finland
Chronic intractable pain
6.5
13.7
22
34
G56.4
ICD-10 Finland
Causalgia
+∞
13.6
13
*
A29
ICPC
General symptom/complaint other
1.7
13.5
265
1646
UJF32
NOMESCO Finland
Coloscopy
1.5
13.5
479
3441
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
3.1
13.4
56
185
N05CF01
ATC
zopiclone; oral
1.5
13.4
607
4584
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
13.4
155
817
1220
FHL
Arthroscopy
2.7
13.3
74
286
J01FF01
ATC
clindamycin; systemic
1.6
13.3
420
2938
N06AX11
ATC
mirtazapine; oral
1.5
13.3
545
4035
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
13.1
426
2996
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
2.5
13.1
83
342
L15
ICPC
Knee symptom/complaint
1.6
13.0
386
2659
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
3.0
12.9
58
200
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.3
12.9
97
432
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
2.5
12.9
84
351
M01AB51
ATC
indometacin, combinations; oral, rectal
3.0
12.8
57
196
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.1
12.7
121
595
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
3.3
12.6
46
140
J01MA02
ATC
ciprofloxacin; systemic
1.5
12.5
700
5493
A03FA02
ATC
cisapride; oral, rectal
1.9
12.5
157
852
L08
ICPC
Shoulder symptom/complaint
1.6
12.4
342
2313
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
12.3
526
3914
J01FA06
ATC
roxithromycin; oral
1.5
12.3
633
4886
M01AE02
ATC
naproxen; oral, rectal
1.4
12.3
807
6518
S18
ICPC
Laceration/cut
1.4
12.2
765
6120
G50.1
ICD-10 Finland
Atypical facial pain
9.7
12.2
24
25
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
3.6
12.1
40
114
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
12.1
537
4022
N03AX09
ATC
lamotrigine; oral
3.0
12.1
52
175
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
12.0
436
3134
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
12.0
202
1202
C03CA01
ATC
furosemide; systemic
1.4
11.8
758
6083
71798
ICD-8 Finland
Other nonarticular rheumatism, Other muscular rheumatism, fibrositis and myalgia
5.2
11.7
24
47
J01DB01
ATC
cefalexin; oral
1.5
11.7
1296
11463
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
1.9
11.7
156
863
J01DA01
ATC
[U] cefalexin
1.4
11.7
995
8388
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
11.6
313
2104
Y0209
ICD-8 Finland
Examination of the nervous system and sensory organs, Nervous system
5.3
11.5
23
44
3557X
ICD-9 Finland
Mononeuritis of lower limb, Other mononeuritis of lower limb
+∞
11.5
11
*
B01AC07
ATC
dipyridamole; systemic
1.9
11.5
147
803
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
3.7
11.4
35
95
SPAT1097
SPAT
Recording of ECG
1.6
11.4
271
1768
NBG10
NOMESCO Finland
Acromioplastia
2.9
11.3
52
182
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
10.6
11.3
21
20
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.8
11.3
190
1130
SPAT1263
SPAT
Sampling
1.4
11.2
656
5160
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.1
11.2
106
520
72599
ICD-8 Finland
Displacement of intervertebral disk, Unspecified site
20.2
11.1
16
8
G50.0
ICD-10 Finland
Trigeminal neuralgia
8.1
11.1
24
30
M01AB08
ATC
etodolac; oral
2.0
11.1
120
619
L13
ICPC
Hip symptom/complaint
1.6
11.0
334
2305
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.8
10.9
171
995
J01AA02
ATC
doxycycline; systemic
1.4
10.8
1271
11263
SPAT1260
SPAT
Consultation of another employee
1.6
10.8
291
1953
J46
ICD-10 Finland
Status asthmaticus
2.8
10.8
54
198
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
2.9
10.8
50
176
M89.0
ICD-10 Finland
Algoneurodystrophy
10.6
10.8
20
19
A03CA02
ATC
clidinium and psycholeptics; oral
2.0
10.8
123
646
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
4.5
10.7
26
59
J01EA01
ATC
trimethoprim; systemic
1.5
10.7
454
3357
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
4.6
10.7
25
55
9242
FHL
Other reconstruction or plastic surgery of shoulder joint (including ac joint)
3.4
10.7
37
109
M50.3
ICD-10 Finland
Other cervical disc degeneration
3.3
10.7
39
119
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.5
10.7
398
2868
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.0
10.6
111
566
I20.09
ICD-10 Finland
Unstable angina
1.9
10.5
137
752
9481
FHL
Detachment or severance of a muscle or tendon
10.1
10.5
20
20
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
14.3
10.5
17
12
Y0499
ICD-8 Finland
Investigation of respiratory system
3.6
10.3
34
97
Y0599
ICD-8 Finland
Investigation of digestive system
3.2
10.3
40
127
ACC19
NOMESCO Finland
Transcision of peripheral nerve: other or unspecified
23.5
10.2
14
6
P01AB01
ATC
metronidazole; oral, rectal
1.4
10.2
574
4467
J01DA09
ATC
[U] cefadroxil
1.5
10.2
390
2825
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.5
10.1
443
3293
M16.9
ICD-10 Finland
Coxarthrosis, unspecified
1.9
10.1
124
668
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
2.8
10.1
50
183
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
10.0
1339
12042
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
10.0
316
2195
C07AB02
ATC
metoprolol; systemic
1.5
10.0
437
3247
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
9.9
289
1973
M18.0
ICD-10 Finland
Primary arthrosis of first carpometacarpal joints, bilateral
4.0
9.8
27
68
M09AX01
ATC
hyaluronic acid; parenteral
2.0
9.7
106
548
7245A
ICD-9 Finland
Other and unspecified disorders of back, Backache, unspecified
3.9
9.7
28
73
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
9.6
106
550
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.9
9.6
113
600
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
9.6
359
2586
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.6
9.5
222
1438
E66.01
ICD-10 Finland
Obesity due to excess calories
2.0
9.5
96
483
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
9.5
255
1710
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
9.5
559
4378
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.7
9.4
164
983
R52.9
ICD-10 Finland
Pain, unspecified
1.8
9.4
153
899
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.6
9.4
54
213
B01AB05
ATC
enoxaparin; parenteral
1.4
9.4
530
4115
A02BA02
ATC
ranitidine; systemic
1.5
9.4
356
2570
G57.9
ICD-10 Finland
Mononeuropathy of lower limb, unspecified
21.8
9.3
13
6
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
4.4
9.3
23
53
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
2.0
9.3
94
473
N05BB01
ATC
hydroxyzine; systemic
2.0
9.3
105
550
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
9.3
528
4106
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
9.3
594
4713
WZC00, ,
SPAT
1.6
9.1
213
1381
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
9.1
260
1767
R4110, ,
SPAT
1.6
9.1
207
1334
N02BE01
ATC
paracetamol; systemic, rectal
1.5
9.0
1467
13507
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
9.0
720
5914
M01AX01
ATC
nabumetone; oral
2.2
9.0
77
364
L17
ICPC
Foot/toe symptom/complaint
1.4
9.0
463
3537
SPAT1254
SPAT
Administration of medicine
1.5
8.9
284
1974
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
8.9
302
2128
WX725
NOMESCO Finland
Noninvasive ventilation
2.1
8.9
86
426
SPAT1216
SPAT
Assessment of functional ability
1.5
8.9
323
2309
WX704
NOMESCO Finland
Intubation
1.9
8.8
115
632
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
8.8
256
1747
4111X
ICD-9 Finland
Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]
3.0
8.8
37
124
S80.0
ICD-10 Finland
Contusion of knee
1.9
8.7
106
569
72800
ICD-8 Finland
Vertebrogenic pain syndrome, Cervicalgia
7.2
8.7
20
28
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
2.9
8.7
39
135
N03AE01
ATC
clonazepam; systemic
2.0
8.7
89
450
H02.3
ICD-10 Finland
Blepharochalasis
1.9
8.6
113
622
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
1.8
8.6
118
660
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.9
8.6
106
573
SPAT1310
SPAT
Counselling related to known health issue
1.4
8.6
474
3660
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
8.6
205
1336
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
2.0
8.5
94
488
R30.0
ICD-10 Finland
Dysuria
2.2
8.5
71
332
78551
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD
2.5
8.5
51
206
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.1
8.5
77
372
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
20.1
8.5
12
6
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.3
8.5
60
262
R53
ICD-10 Finland
Malaise and fatigue
1.4
8.4
431
3280
N62
ICD-10 Finland
Hypertrophy of breast
2.5
8.4
51
207
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
8.4
575
4594
G47.3
ICD-10 Finland
Sleep apnoea
1.5
8.4
290
2049
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
3.2
8.4
33
106
TAB20
NOMESCO Finland
Epidural puncture
4.9
8.4
18
37
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
7.9
8.4
18
23
L12
ICPC
Hand/finger symptom/complaint
1.6
8.3
228
1532
R07.3
ICD-10 Finland
Other chest pain
1.7
8.3
171
1072
SPAT1104
SPAT
Monitoring of emergency patient
1.8
8.3
118
666
H02AB04
ATC
methylprednisolone; systemic
1.6
8.3
231
1558
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
8.3
353
2598
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
8.6
8.3
17
20
L11
ICPC
Wrist symptom/complaint
1.9
8.3
112
623
ABC66
NOMESCO Finland
Decompression of lumbal spinal channel
9.5
8.3
16
17
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.5
8.3
52
215
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
8.3
159
980
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
3.2
8.2
32
102
E66.8
ICD-10 Finland
Other obesity
2.4
8.2
54
228
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
2.0
8.2
92
481
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.6
8.2
219
1464
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
3.9
8.2
23
59
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
3.9
8.2
23
59
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.6
8.1
186
1198
M45
ICD-10 Finland
Ankylosing spondylitis
3.1
8.1
33
108
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.2
8.1
69
325
N04BC05
ATC
pramipexole; oral
1.8
8.1
128
747
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.8
8.1
39
141
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.6
8.0
44
170
-, ,
ICD-10 Finland
2.6
8.0
45
176
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.6
8.0
26
74
A03DA02
ATC
pitofenone and analgesics; systemic
2.6
7.9
45
177
K07.60
ICD-10 Finland
Snapping jaw
2.5
7.9
50
207
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
7.9
612
4976
M03BB52
ATC
chlormezanone, combinations excl. psycholeptics; oral, rectal
2.6
7.9
44
172
M01AH03
ATC
valdecoxib; oral
2.0
7.9
86
446
M02AA10
ATC
ketoprofen; topical
1.5
7.9
256
1787
M15.0
ICD-10 Finland
Primary generalized (osteo)arthrosis
2.3
7.8
57
252
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.7
7.8
146
893
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
3.4
7.8
27
80
79399
ICD-8 Finland
Observation, without need for further medical care, Unspecified
3.8
7.8
23
61
M43.1
ICD-10 Finland
Spondylolisthesis
2.3
7.8
58
259
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.5
7.8
48
197
EB1VA, ,
NOMESCO Finland
1.6
7.8
205
1367
R51.81
ICD-10 Finland
Facial pain NOS
3.1
7.8
32
106
A01AB09
ATC
miconazole; local oral
1.7
7.7
152
942
C10AA05
ATC
atorvastatin; oral
1.3
7.7
746
6260
P03
ICPC
Feeling depressed
1.9
7.7
92
492
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.7
7.7
141
858
K30
ICD-10 Finland
Functional dyspepsia
1.7
7.7
157
983
R01AD09
ATC
mometasone; nasal
1.4
7.7
556
4469
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.2
7.7
65
306
M75.5
ICD-10 Finland
Bursitis of shoulder
2.7
7.7
40
151
SPAT1058
SPAT
PEF monitoring instruction
1.8
7.6
123
722
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.8
7.6
116
670
AA1AD
NOMESCO Finland
CT of head and brain
1.4
7.6
540
4327
59010
ICD-8 Finland
Infections of kidney, Pyelonephritis
3.6
7.6
24
67
C05AA08
ATC
fluocortolone; rectal, topical
1.6
7.6
207
1391
UKC02
NOMESCO Finland
Cystoscopy
1.4
7.5
321
2360
7170A
ICD-9 Finland
Internal derangement of knee, Old bucket handle tear of medial meniscus
2.5
7.5
44
176
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.9
7.5
34
119
81
HP
Angiography of the heart and coronary arteries
1.7
7.4
146
905
A07AA02
ATC
nystatin; oral
1.8
7.4
106
600
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
7.4
241
1680
M62.6
ICD-10 Finland
Muscle strain
2.6
7.4
41
160
Z02.7
ICD-10 Finland
Issue of medical certificate
1.7
7.3
121
715
P76
ICPC
Depressive disorder
2.1
7.3
66
319
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
+∞
7.3
7
*
2505A
ICD-9 Finland
Diabetes mellitus, Diabetes with ophthalmic manifestations[NEUROPATHIA DIABETICA,TYYPPI II]
+∞
7.3
7
*
35701
ICD-8 Finland
Other diseases of peripheral nerves except autonomic, Nervi mediani
+∞
7.3
7
*
7244A
ICD-9 Finland
Other and unspecified disorders of back, Thoracic or lumbosacral neuritis or radiculitis, unspecified
6.9
7.3
17
25
72810
ICD-8 Finland
Vertebrogenic pain syndrome, Cervicocranial syndrome
9.4
7.3
14
15
27799
ICD-8 Finland
Obesity not specified as of endocrine origin
3.9
7.3
21
55
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.7
7.2
142
880
N06AA10
ATC
nortriptyline; systemic
3.0
7.2
31
105
R03AC03
ATC
terbutaline; inhalant
1.5
7.2
200
1347
59203
ICD-8 Finland
Calculus of kidney and ureter, Calculus ureteris
2.9
7.2
33
116
R11
ICD-10 Finland
Nausea and vomiting
1.7
7.2
146
912
L28
ICPC
Limited function/disability (L)
1.4
7.2
380
2903
K01
ICPC
Heart pain
3.0
7.1
31
106
J01CA08
ATC
pivmecillinam; oral
1.3
7.1
582
4754
C10AX09
ATC
ezetimibe; oral
1.5
7.1
254
1805
M75.8
ICD-10 Finland
Other shoulder lesions
2.3
7.1
52
231
71310
ICD-8 Finland
Osteo-arthritis and allied conditions, Spondylarthritis cervicalis
3.8
7.1
21
56
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.3
7.1
51
225
N03AF02
ATC
oxcarbazepine; oral
2.4
7.1
46
194
FN1AD
NOMESCO Finland
CT of coronary arteries
3.1
7.1
29
96
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.6
7.0
151
960
78050
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Vertigo
2.9
7.0
32
113
K29.7
ICD-10 Finland
Gastritis, unspecified
2.1
7.0
61
292
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
6.9
378
2901
J02AC01
ATC
fluconazole; systemic
1.4
6.9
470
3735
M70.7
ICD-10 Finland
Other bursitis of hip
2.3
6.9
48
209
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
6.9
190
1280
A06AC51
ATC
ispaghula, combinations; oral
1.9
6.9
78
411
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
6.8
202
1381
OAB42, ,
SPAT
1.6
6.8
173
1143
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
6.8
79
419
M01AB01
ATC
indometacin; systemic, rectal
1.6
6.8
155
998
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
2.2
6.8
57
268
M77.1
ICD-10 Finland
Lateral epicondylitis
2.1
6.8
65
322
G54.4
ICD-10 Finland
Lumbosacral root disorders, not elsewhere classified
40.2
6.8
8
*
M65.3
ICD-10 Finland
Trigger finger
2.3
6.7
51
230
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.6
6.7
163
1065
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
6.7
153
985
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
3.2
6.7
26
83
M19.2
ICD-10 Finland
Other secondary arthrosis
3.5
6.7
22
63
A04
ICPC
Weakness/tiredness general
1.4
6.7
275
2006
M01AE11
ATC
tiaprofenic acid; oral, rectal
1.9
6.7
79
422
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
6.7
294
2173
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
6.6
642
5358
85000
ICD-8 Finland
Concussion, Current or unspecified
2.6
6.6
37
145
R01AD58
ATC
fluticasone, combinations; nasal
1.5
6.6
236
1676
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.9
6.6
87
481
N07BC02
ATC
methadone; systemic
7.8
6.6
14
18
6453
FHL
Radical surgery of hemorrhoids
2.4
6.6
45
194
R05FB02
ATC
cough suppressants and expectorants; systemic
1.3
6.6
612
5079
AN1
HP
Coronary angiography
1.5
6.6
226
1594
B01AC04
ATC
clopidogrel; oral
1.4
6.6
326
2460
R03BA05
ATC
fluticasone; inhalant
1.4
6.5
253
1825
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
3.8
6.5
19
50
R55
ICD-10 Finland
Syncope and collapse
1.5
6.5
219
1536
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.4
6.5
44
189
R35
ICD-10 Finland
Polyuria
1.7
6.5
122
748
A11
ICPC
Chest pain NOS
1.6
6.5
148
954
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
3.1
6.5
26
85
B01AC06
ATC
acetylsalicylic acid; oral
1.8
6.5
96
551
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.1
6.5
56
267
1225
FHL
Arthroscopy and other therapeutic procedure
3.2
6.4
25
80
34609
ICD-8 Finland
Migraine, Unspecified
3.9
6.4
18
46
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
6.4
176
1183
M01AC01
ATC
piroxicam; systemic, rectal
1.5
6.4
208
1449
N93
ICPC
Carpal tunnel syndrome
7.4
6.4
14
19
N02BE51
ATC
paracetamol, combinations excl. psycholeptics; systemic
3.0
6.4
27
91
L92
ICPC
Shoulder syndrome
2.5
6.4
38
154
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
6.4
53
249
M01AX05
ATC
glucosamine; oral
1.4
6.3
349
2677
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.7
6.3
109
653
72830
ICD-8 Finland
Vertebrogenic pain syndrome, Radicular syndrome of upper limbs
8.2
6.3
13
16
9253
FHL
Manipulation under anesthesia or regression and plastering
3.6
6.3
20
56
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
3.6
6.3
20
56
72820
ICD-8 Finland
Vertebrogenic pain syndrome, Diffuse syndrome cerviocobrachial
5.5
6.3
17
31
6561
FHL
Removal of fasteners and related measures
11.1
6.3
11
10
C08CA07
ATC
nisoldipine; oral
2.5
6.3
37
149
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.8
6.3
83
460
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
1.9
6.3
79
431
AEA24
NOMESCO Finland
Removal of spinal stimulation elecrode
18.1
6.3
9
5
N06AB04
ATC
citalopram; systemic
1.4
6.3
303
2275
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
2.4
6.3
42
180
3534A
ICD-9 Finland
Nerve root and plexus disorders, Lumbosacral root lesions, not elsewhere classified[RADICULOPATHIA LUMBOSACRALIS]
+∞
6.3
6
*
M79.1
ICD-10 Finland
Myalgia
1.5
6.2
181
1232
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
2.2
6.2
47
212
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
6.2
343
2631
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.3
6.2
44
193
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
6.2
250
1816
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.9
6.2
77
418
F01
ICPC
Eye pain
2.5
6.2
37
150
WZC30, ,
SPAT
1.6
6.2
126
789
7865A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Chest pain
2.3
6.2
43
187
R07.1
ICD-10 Finland
Chest pain on breathing
3.1
6.2
25
82
J01CA04
ATC
amoxicillin; systemic
1.3
6.2
1205
10971
J01FA10
ATC
azithromycin; systemic
1.3
6.2
695
5903
E9199
ICD-8 Finland
Over-exertion and strenuous movements
4.0
6.2
17
43
R03BA01
ATC
beclometasone; inhalant
1.5
6.2
206
1444
L90
ICPC
Osteoarthrosis of knee
1.7
6.2
113
689
L02
ICPC
Back symptom/complaint
1.6
6.2
124
775
1530
FHL
Urethrocystoscopy
2.3
6.2
44
194
8404A
ICD-9 Finland
Sprains and strains of shoulder and upper arm, Rotator cuff (capsule)
3.4
6.1
21
62
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.6
6.1
125
784
R03BA02
ATC
budesonide; inhalant
1.4
6.1
252
1839
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
2.7
6.1
31
116
N06AB10
ATC
escitalopram; oral
1.5
6.1
224
1600
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
6.1
232
1670
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
3.6
6.0
19
53
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.7
6.0
30
111

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
gabapentin; oral
N02BF01 [955005]
2.3e+00
2.7e+00
2.7e+00
1.0e+50
3.5e+00
2.9e+00
2.0e+00
cases:3.53%
controls:0.38%
cases:3.19%
controls:0.22%
cases:1.14%
controls:0.07%
cases:0.57%
controls:0.00%
cases:2.28%
controls:0.07%
cases:3.89%
controls:0.22%
cases:4.65%
controls:0.67%
31
31
846
8095
28
18
849
8108
10
6
867
8120
5
0
872
8126
20
6
857
8119
34
18
839
8069
40
53
821
7910
Physical Medicine And Rehabilitation
25 [38004468]
1.5e+00
2.6e+00
3.2e+00
1.0e+50
3.3e+00
2.9e+00
1.7e+00
cases:7.41%
controls:1.72%
cases:6.50%
controls:0.52%
cases:1.71%
controls:0.07%
cases:11.40%
controls:0.00%
cases:4.10%
controls:0.16%
cases:10.42%
controls:0.66%
cases:9.87%
controls:1.95%
65
140
812
7986
57
42
820
8084
15
6
862
8120
100
0
777
8126
36
13
841
8112
91
53
782
8034
85
155
776
7808
pregabalin; oral
N02BF02 [955152]
2.0e+00
2.4e+00
2.2e+00
—
2.8e+00
2.3e+00
1.7e+00
cases:4.45%
controls:0.65%
cases:4.45%
controls:0.42%
cases:1.71%
controls:0.18%
—
—
cases:1.94%
controls:0.12%
cases:4.24%
controls:0.42%
cases:6.16%
controls:1.22%
39
53
838
8073
39
34
838
8092
15
15
862
8111
—
17
10
860
8115
37
34
836
8053
53
97
808
7866
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
1.4e+00
2.1e+00
2.5e+00
—
2.7e+00
2.0e+00
1.2e+00
cases:6.84%
controls:1.72%
cases:6.16%
controls:0.81%
cases:1.82%
controls:0.15%
—
—
cases:1.94%
controls:0.14%
cases:4.58%
controls:0.64%
cases:6.50%
controls:2.08%
60
140
817
7986
54
66
823
8060
16
12
861
8114
—
17
11
860
8114
40
52
833
8035
56
166
805
7797
Lumbar and other intervertebral disc disorders with radiculopathy
M51.1 [45562747]
2.5e+00
3.1e+00
—
1.0e+50
—
4.0e+00
2.0e+00
cases:3.65%
controls:0.31%
cases:3.53%
controls:0.16%
—
—
cases:1.03%
controls:0.00%
—
—
cases:3.78%
controls:0.07%
cases:3.48%
controls:0.46%
32
25
845
8101
31
13
846
8113
—
9
0
868
8126
—
33
6
840
8081
30
37
831
7926
Orthopedic Surgery
20 [38004465]
1.1e+00
1.9e+00
2.5e+00
1.0e+50
2.5e+00
1.9e+00
1.1e+00
cases:10.03%
controls:3.45%
cases:8.89%
controls:1.50%
cases:2.51%
controls:0.21%
cases:5.02%
controls:0.00%
cases:2.74%
controls:0.23%
cases:8.71%
controls:1.47%
cases:13.01%
controls:4.53%
88
280
789
7846
78
122
799
8004
22
17
855
8109
44
0
833
8126
24
19
853
8106
76
119
797
7968
112
361
749
7602
Outpatient Visit
OP [9202]
4.2e-01
8.2e-01
1.1e+00
5.6e+00
1.6e+00
9.1e-01
5.0e-01
cases:30.56%
controls:22.50%
cases:27.14%
controls:14.08%
cases:8.55%
controls:2.95%
cases:28.85%
controls:0.15%
cases:12.88%
controls:2.98%
cases:29.32%
controls:14.36%
cases:43.67%
controls:32.05%
268
1828
609
6298
238
1144
639
6982
75
240
802
7886
253
12
624
8114
113
242
764
7883
256
1161
617
6926
376
2552
485
5411
Lumbago with sciatica
M54.4 [45553205]
1.7e+00
3.5e+00
—
1.0e+50
—
3.6e+00
2.1e+00
cases:2.05%
controls:0.38%
cases:2.05%
controls:0.06%
—
—
cases:0.57%
controls:0.00%
—
—
cases:2.29%
controls:0.06%
cases:3.83%
controls:0.50%
18
31
859
8095
18
5
859
8121
—
5
0
872
8126
—
20
5
853
8082
33
40
828
7923
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
1.9e+00
2.5e+00
—
1.0e+50
—
3.9e+00
2.7e+00
cases:1.25%
controls:0.20%
cases:1.60%
controls:0.14%
—
—
cases:2.28%
controls:0.00%
—
—
cases:2.98%
controls:0.06%
cases:3.48%
controls:0.25%
11
16
866
8110
14
11
863
8115
—
20
0
857
8126
—
26
5
847
8082
30
20
831
7943
oxycodone; oral, parenteral
N02AA05 [21604260]
1.7e+00
2.9e+00
2.4e+00
—
—
1.9e+00
1.5e+00
cases:1.03%
controls:0.18%
cases:1.37%
controls:0.07%
cases:0.68%
controls:0.06%
—
—
—
—
cases:1.49%
controls:0.22%
cases:2.32%
controls:0.54%
9
15
868
8111
12
6
865
8120
6
5
871
8121
—
—
13
18
860
8069
20
43
841
7920
General Surgery
2 [38004447]
8.6e-01
1.6e+00
1.5e+00
1.0e+50
2.9e+00
1.8e+00
1.1e+00
cases:29.30%
controls:14.89%
cases:17.45%
controls:4.20%
cases:2.74%
controls:0.65%
cases:48.92%
controls:0.00%
cases:9.81%
controls:0.58%
cases:22.22%
controls:4.46%
cases:34.03%
controls:14.58%
257
1210
620
6916
153
341
724
7785
24
53
853
8073
429
0
448
8126
86
47
791
8078
194
361
679
7726
293
1161
568
6802
Neurosurgery
14 [38004459]
1.9e+00
2.5e+00
—
1.0e+50
—
2.4e+00
2.3e+00
cases:3.76%
controls:0.55%
cases:2.28%
controls:0.20%
—
—
cases:2.28%
controls:0.00%
—
—
cases:2.41%
controls:0.22%
cases:6.16%
controls:0.64%
33
45
844
8081
20
16
857
8110
—
20
0
857
8126
—
21
18
852
8069
53
51
808
7912
Spinal stenosis
M48.0 [45557888]
2.2e+00
2.2e+00
—
1.0e+50
—
1.9e+00
1.8e+00
cases:2.39%
controls:0.26%
cases:1.14%
controls:0.12%
—
—
cases:0.68%
controls:0.00%
—
—
cases:1.03%
controls:0.15%
cases:2.56%
controls:0.43%
21
21
856
8105
10
10
867
8116
—
6
0
871
8126
—
9
12
864
8075
22
34
839
7929
Other specified intervertebral disc degeneration
M51.3 [45591865]
2.0e+00
2.9e+00
—
—
—
—
2.9e+00
cases:1.60%
controls:0.22%
cases:1.37%
controls:0.07%
—
—
—
—
—
—
—
—
cases:3.60%
controls:0.20%
14
18
863
8108
12
6
865
8120
—
—
—
—
31
16
830
7947
Inpatient Visit
IP [9201]
7.5e-01
1.2e+00
8.8e-01
—
2.8e+00
1.5e+00
9.9e-01
cases:30.67%
controls:17.33%
cases:15.62%
controls:5.22%
cases:1.82%
controls:0.76%
—
—
cases:9.12%
controls:0.62%
cases:20.62%
controls:5.63%
cases:36.93%
controls:17.85%
269
1408
608
6718
137
424
740
7702
16
62
861
8064
—
80
50
797
8075
180
455
693
7632
318
1421
543
6542
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
1.8e+00
2.1e+00
—
—
—
1.6e+00
1.6e+00
cases:1.25%
controls:0.21%
cases:1.25%
controls:0.16%
—
—
—
—
—
—
cases:1.15%
controls:0.22%
cases:2.21%
controls:0.45%
11
17
866
8109
11
13
866
8113
—
—
—
10
18
863
8069
19
36
842
7927
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
7.6e-01
9.9e-01
2.1e+00
—
1.9e+00
7.7e-01
5.3e-01
cases:11.06%
controls:5.50%
cases:5.47%
controls:2.10%
cases:1.25%
controls:0.16%
—
—
cases:1.37%
controls:0.20%
cases:3.55%
controls:1.68%
cases:9.41%
controls:5.74%
97
447
780
7679
48
171
829
7955
11
13
866
8113
—
12
16
865
8109
31
136
842
7951
81
457
780
7506
Dorsalgia, unspecified
M54.9 [45538791]
8.0e-01
2.6e+00
—
—
—
2.6e+00
1.5e+00
cases:0.68%
controls:0.31%
cases:1.03%
controls:0.07%
—
—
—
—
—
—
cases:0.80%
controls:0.06%
cases:1.16%
controls:0.26%
6
25
871
8101
9
6
868
8120
—
—
—
7
5
866
8082
10
21
851
7942
amitriptyline; oral, parenteral
N06AA09 [21604696]
1.3e+00
1.7e+00
—
—
1.4e+00
1.7e+00
1.7e+00
cases:3.08%
controls:0.89%
cases:2.39%
controls:0.43%
—
—
—
—
cases:0.68%
controls:0.17%
cases:2.75%
controls:0.49%
cases:5.92%
controls:1.19%
27
72
850
8054
21
35
856
8091
—
—
6
14
871
8111
24
40
849
8047
51
95
810
7868
Trochanteric bursitis
M70.6 [45606304]
1.7e+00
—
—
—
—
2.8e+00
1.7e+00
cases:1.37%
controls:0.26%
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.06%
cases:1.51%
controls:0.29%
12
21
865
8105
—
—
—
—
9
5
864
8082
13
23
848
7940
etoricoxib; oral
M01AH05 [21603996]
9.3e-01
1.4e+00
—
—
2.0e+00
1.1e+00
4.7e-01
cases:7.64%
controls:3.16%
cases:5.02%
controls:1.32%
—
—
—
—
cases:1.25%
controls:0.17%
cases:3.89%
controls:1.27%
cases:8.01%
controls:5.17%
67
257
810
7869
44
107
833
8019
—
—
11
14
866
8111
34
103
839
7984
69
412
792
7551
Neurology
13 [38004458]
7.0e-01
9.7e-01
1.2e+00
1.0e+50
1.6e+00
1.4e+00
9.8e-01
cases:5.82%
controls:2.98%
cases:3.53%
controls:1.37%
cases:1.14%
controls:0.36%
cases:3.88%
controls:0.00%
cases:1.71%
controls:0.34%
cases:5.50%
controls:1.36%
cases:9.52%
controls:3.82%
51
242
826
7884
31
111
846
8015
10
29
867
8097
34
0
843
8126
15
28
862
8097
48
110
825
7977
82
304
779
7659
One hour or less
ZXE00 [2001311394]
5.6e-01
1.2e+00
—
—
2.2e+00
1.4e+00
7.2e-01
cases:3.31%
controls:1.92%
cases:1.82%
controls:0.55%
—
—
—
—
cases:0.68%
controls:0.07%
cases:2.18%
controls:0.52%
cases:3.60%
controls:1.78%
29
156
848
7970
16
45
861
8081
—
—
6
6
871
8119
19
42
854
8045
31
142
830
7821
Respiratory and circulatory monitoring
WX700 [2001310817]
1.1e+00
1.8e+00
—
—
—
2.5e+00
1.3e+00
cases:1.25%
controls:0.41%
cases:0.80%
controls:0.14%
—
—
—
—
—
—
cases:1.03%
controls:0.09%
cases:2.09%
controls:0.60%
11
33
866
8093
7
11
870
8115
—
—
—
9
7
864
8080
18
48
843
7915
Vertebrogenic pain syndrome, Radicula syndrome of lower limbs
72880 [2000304599]
1.7e+00
—
—
—
1.0e+50
—
3.5e+00
cases:2.05%
controls:0.38%
—
—
—
—
—
—
cases:1.03%
controls:0.00%
—
—
cases:2.56%
controls:0.08%
18
31
859
8095
—
—
—
9
0
868
8125
—
22
6
839
7957
duloxetine; oral
N06AX21 [21604749]
1.5e+00
—
—
—
1.9e+00
2.2e+00
1.4e+00
cases:1.25%
controls:0.27%
—
—
—
—
—
—
cases:0.57%
controls:0.09%
cases:1.83%
controls:0.21%
cases:1.74%
controls:0.44%
11
22
866
8104
—
—
—
5
7
872
8118
16
17
857
8070
15
35
846
7928
Displacement of intervertebral disk, Lumbalis cum prolapsu disci
72510 [2000304573]
1.9e+00
—
—
—
1.0e+50
—
3.2e+00
cases:2.51%
controls:0.37%
—
—
—
—
—
—
cases:3.42%
controls:0.00%
—
—
cases:3.14%
controls:0.14%
22
30
855
8096
—
—
—
30
0
847
8125
—
27
11
834
7952
Outpatient Hospital
22 [8756]
6.3e-01
1.0e+00
6.2e-01
—
1.5e+00
1.2e+00
6.2e-01
cases:14.82%
controls:8.49%
cases:7.07%
controls:2.66%
cases:0.57%
controls:0.31%
—
—
cases:1.25%
controls:0.27%
cases:6.99%
controls:2.26%
cases:13.59%
controls:7.82%
130
690
747
7436
62
216
815
7910
5
25
872
8101
—
11
22
866
8103
61
183
812
7904
117
623
744
7340
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
5.5e-01
8.8e-01
1.1e+00
—
1.1e+00
8.5e-01
5.4e-01
cases:11.17%
controls:6.74%
cases:8.55%
controls:3.72%
cases:1.71%
controls:0.60%
—
—
cases:1.71%
controls:0.60%
cases:8.36%
controls:3.76%
cases:17.31%
controls:10.84%
98
548
779
7578
75
302
802
7824
15
49
862
8077
—
15
49
862
8076
73
304
800
7783
149
863
712
7100
Hand Surgery
40 [38004480]
1.5e+00
1.9e+00
—
1.0e+50
—
1.5e+00
1.4e+00
cases:1.94%
controls:0.46%
cases:0.80%
controls:0.12%
—
—
cases:0.68%
controls:0.00%
—
—
cases:0.57%
controls:0.12%
cases:2.32%
controls:0.57%
17
37
860
8089
7
10
870
8116
—
6
0
871
8126
—
5
10
868
8077
20
45
841
7918
Physiotherapist
Z3226 [2001311560]
8.1e-01
2.4e+00
—
1.0e+50
—
2.2e+00
7.6e-01
cases:1.37%
controls:0.62%
cases:1.94%
controls:0.18%
—
—
cases:0.57%
controls:0.00%
—
—
cases:2.41%
controls:0.27%
cases:1.63%
controls:0.77%
12
50
865
8076
17
15
860
8111
—
5
0
872
8126
—
21
22
852
8065
14
61
847
7902
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
8.5e-01
1.5e+00
2.0e+00
—
—
1.4e+00
8.5e-01
cases:4.33%
controls:1.91%
cases:2.28%
controls:0.53%
cases:0.57%
controls:0.07%
—
—
—
—
cases:2.06%
controls:0.52%
cases:4.99%
controls:2.20%
38
155
839
7971
20
43
857
8083
5
6
872
8120
—
—
18
42
855
8045
43
175
818
7788
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
8.5e-01
1.5e+00
2.0e+00
—
—
1.4e+00
8.5e-01
cases:4.33%
controls:1.91%
cases:2.28%
controls:0.53%
cases:0.57%
controls:0.07%
—
—
—
—
cases:2.06%
controls:0.52%
cases:4.99%
controls:2.20%
38
155
839
7971
20
43
857
8083
5
6
872
8120
—
—
18
42
855
8045
43
175
818
7788
Low back pain
M54.5 [45553207]
8.4e-01
1.7e+00
—
—
—
1.7e+00
1.2e+00
cases:1.94%
controls:0.85%
cases:2.39%
controls:0.46%
—
—
—
—
—
—
cases:2.18%
controls:0.40%
cases:4.53%
controls:1.46%
17
69
860
8057
21
37
856
8089
—
—
—
19
32
854
8055
39
116
822
7847
General Practice
1 [38004446]
4.7e-01
1.4e+00
—
1.0e+50
1.7e+00
8.3e-01
5.8e-01
cases:3.99%
controls:2.54%
cases:4.45%
controls:1.13%
—
—
cases:0.91%
controls:0.00%
cases:0.91%
controls:0.16%
cases:2.75%
controls:1.21%
cases:6.74%
controls:3.88%
35
206
842
7920
39
92
838
8034
—
8
0
869
8126
8
13
869
8112
24
98
849
7989
58
309
803
7654
Exposure to unspecified factor
X59 [45756412]
9.9e-01
2.0e+00
—
—
—
2.5e+00
8.2e-01
cases:1.25%
controls:0.47%
cases:0.80%
controls:0.11%
—
—
—
—
—
—
cases:0.92%
controls:0.07%
cases:1.74%
controls:0.78%
11
38
866
8088
7
9
870
8117
—
—
—
8
6
865
8081
15
62
846
7901
Other primary coxarthrosis
M16.1 [45591741]
2.0e+00
2.5e+00
—
—
—
1.7e+00
9.6e-01
cases:1.48%
controls:0.20%
cases:1.14%
controls:0.10%
—
—
—
—
—
—
cases:0.80%
controls:0.15%
cases:1.39%
controls:0.54%
13
16
864
8110
10
8
867
8118
—
—
—
7
12
866
8075
12
43
849
7920
lansoprazole; oral
A02BC03 [21600098]
9.6e-01
1.3e+00
—
—
1.2e+00
1.2e+00
9.4e-01
cases:4.33%
controls:1.71%
cases:2.85%
controls:0.81%
—
—
—
—
cases:0.57%
controls:0.17%
cases:2.86%
controls:0.88%
cases:4.88%
controls:1.97%
38
139
839
7987
25
66
852
8060
—
—
5
14
872
8111
25
71
848
8016
42
157
819
7806
Inpatient Hospital
21 [8717]
4.4e-01
9.1e-01
6.8e-01
1.0e+50
1.4e+00
9.0e-01
6.8e-01
cases:18.24%
controls:12.54%
cases:9.35%
controls:3.99%
cases:1.25%
controls:0.64%
cases:4.56%
controls:0.00%
cases:1.82%
controls:0.44%
cases:8.48%
controls:3.62%
cases:18.70%
controls:10.46%
160
1019
717
7107
82
324
795
7802
11
52
866
8074
40
0
837
8126
16
36
861
8089
74
293
799
7794
161
833
700
7130
ibuprofen
R02AX02 [1588667]
5.4e-01
6.5e-01
1.3e+00
—
9.1e-01
6.1e-01
3.4e-01
cases:17.45%
controls:10.98%
cases:9.35%
controls:5.12%
cases:2.62%
controls:0.75%
—
—
cases:2.05%
controls:0.84%
cases:9.39%
controls:5.32%
cases:17.31%
controls:12.92%
153
892
724
7234
82
416
795
7710
23
61
854
8065
—
18
68
859
8057
82
430
791
7657
149
1029
712
6934
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
5.4e-01
6.5e-01
1.3e+00
—
9.1e-01
6.1e-01
3.4e-01
cases:17.45%
controls:10.98%
cases:9.35%
controls:5.12%
cases:2.62%
controls:0.75%
—
—
cases:2.05%
controls:0.84%
cases:9.39%
controls:5.32%
cases:17.31%
controls:12.92%
153
892
724
7234
82
416
795
7710
23
61
854
8065
—
18
68
859
8057
82
430
791
7657
149
1029
712
6934
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
2.6e+00
—
—
—
—
—
1.7e+00
cases:1.48%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.21%
13
9
864
8117
—
—
—
—
—
10
17
851
7946
Pulmonary Disease
29 [38004472]
7.9e-01
5.7e-01
1.9e+00
—
—
9.1e-01
6.7e-01
cases:4.79%
controls:2.23%
cases:2.05%
controls:1.17%
cases:0.80%
controls:0.12%
—
—
—
—
cases:2.63%
controls:1.08%
cases:5.23%
controls:2.75%
42
181
835
7945
18
95
859
8031
7
10
870
8116
—
—
23
87
850
8000
45
219
816
7744
Pain in joint
M25.5 [45586941]
1.2e+00
1.9e+00
—
—
—
5.2e-01
1.1e+00
cases:2.62%
controls:0.79%
cases:1.48%
controls:0.22%
—
—
—
—
—
—
cases:0.69%
controls:0.41%
cases:3.83%
controls:1.31%
23
64
854
8062
13
18
864
8108
—
—
—
6
33
867
8054
33
104
828
7859
Low back symptom/complaint
L03 [2002000628]
8.3e-01
1.5e+00
—
—
—
1.5e+00
1.2e+00
cases:1.37%
controls:0.60%
cases:1.14%
controls:0.26%
—
—
—
—
—
—
cases:1.03%
controls:0.22%
cases:3.02%
controls:0.95%
12
49
865
8077
10
21
867
8105
—
—
—
9
18
864
8069
26
76
835
7887
Cervical disc disorder with radiculopathy
M50.1 [45596588]
2.1e+00
—
—
—
—
—
2.1e+00
cases:0.80%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.10%
7
8
870
8118
—
—
—
—
—
7
8
854
7955
Pain in limb
M79.6 [45587063]
1.1e+00
1.8e+00
—
—
—
9.0e-01
1.2e+00
cases:2.85%
controls:0.94%
cases:2.17%
controls:0.36%
—
—
—
—
—
—
cases:1.15%
controls:0.47%
cases:5.57%
controls:1.68%
25
76
852
8050
19
29
858
8097
—
—
—
10
38
863
8049
48
134
813
7829
Physiotherapy
R4110 [2001310233]
3.1e-01
2.1e+00
2.2e+00
1.0e+50
—
2.1e+00
6.7e-01
cases:1.25%
controls:0.92%
cases:2.74%
controls:0.36%
cases:0.57%
controls:0.06%
cases:0.57%
controls:0.00%
—
—
cases:2.52%
controls:0.32%
cases:2.56%
controls:1.32%
11
75
866
8051
24
29
853
8097
5
5
872
8121
5
0
872
8126
—
22
26
851
8061
22
105
839
7858
Emergency Room Visit
ER [9203]
4.2e-01
8.2e-01
6.2e-01
—
1.4e+00
9.4e-01
4.9e-01
cases:14.48%
controls:9.98%
cases:7.53%
controls:3.47%
cases:1.03%
controls:0.55%
—
—
cases:1.94%
controls:0.48%
cases:8.25%
controls:3.40%
cases:16.03%
controls:10.49%
127
811
750
7315
66
282
811
7844
9
45
868
8081
—
17
39
860
8086
72
275
801
7812
138
835
723
7128
codeine and paracetamol
N02AJ06 [1123647]
8.2e-01
1.3e+00
1.6e+00
—
1.3e+00
1.1e+00
6.0e-01
cases:5.82%
controls:2.66%
cases:4.33%
controls:1.18%
cases:0.91%
controls:0.18%
—
—
cases:0.91%
controls:0.25%
cases:4.12%
controls:1.36%
cases:8.01%
controls:4.57%
51
216
826
7910
38
96
839
8030
8
15
869
8111
—
8
20
869
8105
36
110
837
7977
69
364
792
7599
Sciatica
M54.3 [45586994]
2.1e+00
—
—
—
—
—
1.8e+00
cases:0.68%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.14%
6
7
871
8119
—
—
—
—
—
7
11
854
7952
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
1.7e+00
—
—
—
—
—
2.0e+00
cases:1.03%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.25%
9
15
868
8111
—
—
—
—
—
16
20
845
7943
naproxen and esomeprazole; oral
M01AE52 [40254096]
1.8e+00
1.9e+00
—
—
—
1.4e+00
6.0e-01
cases:1.60%
controls:0.27%
cases:1.03%
controls:0.15%
—
—
—
—
—
—
cases:0.69%
controls:0.17%
cases:1.05%
controls:0.58%
14
22
863
8104
9
12
868
8114
—
—
—
6
14
867
8073
9
46
852
7917
meloxicam; oral, parenteral, rectal
M01AC06 [21603965]
1.0e+00
1.5e+00
—
—
—
1.1e+00
3.8e-01
cases:4.68%
controls:1.77%
cases:2.39%
controls:0.54%
—
—
—
—
—
—
cases:1.72%
controls:0.58%
cases:2.90%
controls:2.01%
41
144
836
7982
21
44
856
8082
—
—
—
15
47
858
8040
25
160
836
7803
Primary coxarthrosis, bilateral
M16.0 [45543482]
2.0e+00
—
—
—
—
—
1.6e+00
cases:0.80%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.21%
7
9
870
8117
—
—
—
—
—
9
17
852
7946
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
1.9e+00
—
—
—
—
—
1.6e+00
cases:1.25%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.29%
11
15
866
8111
—
—
—
—
—
12
23
849
7940
General anesthesia, balanced
WX408 [2001310808]
8.4e-01
1.9e+00
—
—
—
1.6e+00
7.6e-01
cases:2.05%
controls:0.90%
cases:1.71%
controls:0.26%
—
—
—
—
—
—
cases:1.03%
controls:0.21%
cases:1.86%
controls:0.88%
18
73
859
8053
15
21
862
8105
—
—
—
9
17
864
8070
16
70
845
7893
More than one and less than three hours
ZXE10 [2001311401]
5.7e-01
1.3e+00
—
—
—
1.4e+00
8.4e-01
cases:2.85%
controls:1.64%
cases:1.60%
controls:0.44%
—
—
—
—
—
—
cases:1.72%
controls:0.45%
cases:3.37%
controls:1.48%
25
133
852
7993
14
36
863
8090
—
—
—
15
36
858
8051
29
118
832
7845
Case Management Agency
251B00000X [38004193]
1.0e-01
1.3e-01
5.0e-01
2.8e+00
5.1e-01
9.2e-02
1.0e-01
cases:17.67%
controls:16.21%
cases:13.45%
controls:11.96%
cases:6.16%
controls:3.84%
cases:3.88%
controls:0.25%
cases:6.61%
controls:4.06%
cases:13.52%
controls:12.48%
cases:29.15%
controls:27.05%
155
1317
722
6809
118
972
759
7154
54
312
823
7814
34
20
843
8106
58
330
819
7795
118
1009
755
7078
251
2154
610
5809
Scheduled procedure
ZXD10 [2001311387]
6.8e-01
1.0e+00
—
1.0e+50
2.0e+00
1.7e+00
9.0e-01
cases:3.88%
controls:1.99%
cases:1.60%
controls:0.59%
—
—
cases:0.68%
controls:0.00%
cases:0.57%
controls:0.07%
cases:2.63%
controls:0.51%
cases:3.95%
controls:1.65%
34
162
843
7964
14
48
863
8078
—
6
0
871
8126
5
6
872
8119
23
41
850
8046
34
131
827
7832
rivaroxaban; oral
B01AF01 [43534761]
1.5e+00
—
—
—
—
1.5e+00
9.2e-01
cases:1.03%
controls:0.22%
—
—
—
—
—
—
—
—
cases:1.03%
controls:0.22%
cases:1.28%
controls:0.51%
9
18
868
8108
—
—
—
—
9
18
864
8069
11
41
850
7922
Laceration/cut
S18 [2002000983]
9.2e-01
1.2e+00
-1.0e+50
—
—
1.3e+00
7.0e-01
cases:2.62%
controls:1.06%
cases:1.37%
controls:0.42%
cases:0.00%
controls:0.11%
—
—
—
—
cases:1.49%
controls:0.41%
cases:3.83%
controls:1.95%
23
86
854
8040
12
34
865
8092
0
9
877
8117
—
—
13
33
860
8054
33
155
828
7808
tizanidine; oral
M03BX02 [21604116]
7.5e-01
7.3e-01
1.0e+00
—
—
8.6e-01
4.9e-01
cases:9.35%
controls:4.63%
cases:3.42%
controls:1.69%
cases:0.57%
controls:0.21%
—
—
—
—
cases:2.98%
controls:1.29%
cases:8.13%
controls:5.12%
82
376
795
7750
30
137
847
7989
5
17
872
8109
—
—
26
104
847
7983
70
408
791
7555
Psychiatry
26 [38004469]
4.4e-01
8.5e-01
8.9e-01
—
7.5e-01
9.8e-01
8.3e-01
cases:2.85%
controls:1.86%
cases:2.39%
controls:1.03%
cases:0.68%
controls:0.28%
—
—
cases:0.57%
controls:0.27%
cases:2.63%
controls:1.00%
cases:4.65%
controls:2.08%
25
151
852
7975
21
84
856
8042
6
23
871
8103
—
5
22
872
8103
23
81
850
8006
40
166
821
7797
Pharmacy visit
OMOP4822462 [581458]
-4.5e-03
1.6e-01
3.2e-01
1.8e+00
4.8e-01
1.4e-01
-1.8e-02
cases:34.21%
controls:34.31%
cases:33.52%
controls:30.04%
cases:18.24%
controls:13.96%
cases:3.42%
controls:0.58%
cases:20.87%
controls:14.07%
cases:33.56%
controls:30.53%
cases:36.82%
controls:37.23%
300
2788
577
5338
294
2441
583
5685
160
1134
717
6992
30
47
847
8079
183
1143
694
6982
293
2469
580
5618
317
2965
544
4998
Internal Medicine
11 [38004456]
6.0e-01
6.9e-01
5.7e-01
—
7.9e-01
7.9e-01
5.2e-01
cases:15.05%
controls:8.89%
cases:6.84%
controls:3.57%
cases:1.25%
controls:0.71%
—
—
cases:1.37%
controls:0.63%
cases:7.67%
controls:3.65%
cases:16.72%
controls:10.64%
132
722
745
7404
60
290
817
7836
11
58
866
8068
—
12
51
865
8074
67
295
806
7792
144
847
717
7116
Other primary gonarthrosis
M17.1 [45596493]
1.4e+00
1.2e+00
—
—
—
1.1e+00
1.0e+00
cases:2.51%
controls:0.60%
cases:1.14%
controls:0.36%
—
—
—
—
—
—
cases:1.15%
controls:0.40%
cases:2.56%
controls:0.92%
22
49
855
8077
10
29
867
8097
—
—
—
10
32
863
8055
22
73
839
7890
Back syndrome with radiating pain
L86 [2002000705]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.09%
—
—
—
—
—
—
9
7
852
7956
Vertebrogenic pain syndrome, Lumbalgia
72870 [2000304598]
2.5e+00
—
—
—
—
1.0e+50
—
cases:1.14%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.00%
—
—
10
8
867
8118
—
—
—
—
5
0
868
8087
—
Thorax X-ray examination
GD1AA [2001303617]
4.2e-01
1.3e+00
—
—
—
1.1e+00
5.3e-01
cases:1.94%
controls:1.28%
cases:1.71%
controls:0.47%
—
—
—
—
—
—
cases:1.72%
controls:0.57%
cases:3.48%
controls:2.07%
17
104
860
8022
15
38
862
8088
—
—
—
15
46
858
8041
30
165
831
7798
Microsurgical excision of lumbar intervertebral disc displacement
ABC16 [2001300466]
2.4e+00
—
—
—
—
—
—
cases:0.68%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
871
8121
—
—
—
—
—
—
Decompression of lumbar nerve roots
ABC36 [2001300475]
2.4e+00
—
—
—
—
—
1.9e+00
cases:0.68%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.09%
6
5
871
8121
—
—
—
—
—
5
7
856
7956
Intervertebral disk disorders, Postlaminectomy syndrome[SYNDROMA LUMBOSACRALE POSTLAMINECTOMIAM]
7228C [2000406022]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.06%
—
—
—
—
—
—
6
5
855
7958
Other chronic pain
R52.2 [45568139]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.06%
—
—
—
—
—
—
6
5
855
7958
Hospital outpatient
ZY010 [2001311599]
—
—
—
—
—
-1.0e+50
2.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.81%
controls:0.08%
—
—
—
—
—
0
5
873
8082
7
6
854
7957
Radiculopathy
M54.1 [45577287]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.10%
—
—
—
—
—
—
9
8
852
7955
Lumbar spine X-ray examination without contrast
NA3AA [2001307026]
1.2e+00
—
—
—
—
—
2.3e+00
cases:0.57%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.14%
5
14
872
8112
—
—
—
—
—
12
11
849
7952
Rotator cuff syndrome
M75.1 [45596678]
1.5e+00
9.3e-01
—
—
—
1.2e+00
7.9e-01
cases:2.28%
controls:0.50%
cases:0.68%
controls:0.27%
—
—
—
—
—
—
cases:1.03%
controls:0.32%
cases:2.67%
controls:1.23%
20
41
857
8085
6
22
871
8104
—
—
—
9
26
864
8061
23
98
838
7865
enoxaparin; parenteral
B01AB05 [21600976]
9.9e-01
1.3e+00
—
—
—
1.2e+00
6.5e-01
cases:2.05%
controls:0.78%
cases:1.48%
controls:0.41%
—
—
—
—
—
—
cases:0.92%
controls:0.28%
cases:2.32%
controls:1.23%
18
63
859
8063
13
33
864
8093
—
—
—
8
23
865
8064
20
98
841
7865
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
7227C [2000406019]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.21%
controls:0.24%
—
—
—
—
—
—
19
19
842
7944
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
8.0e-01
1.3e+00
—
—
—
9.4e-01
9.0e-01
cases:1.82%
controls:0.82%
cases:1.25%
controls:0.33%
—
—
—
—
—
—
cases:0.92%
controls:0.36%
cases:2.90%
controls:1.21%
16
67
861
8059
11
27
866
8099
—
—
—
8
29
865
8058
25
96
836
7867
Rheumatism, unspecified
M79.0 [45567658]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.11%
—
—
—
—
—
—
9
9
852
7954
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
—
—
—
—
—
2.2e+00
1.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.80%
controls:0.09%
cases:1.28%
controls:0.40%
—
—
—
—
—
7
7
866
8080
11
32
850
7931
Polyneuropathy, unspecified
G62.9 [45566898]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.10%
—
—
—
—
—
—
8
8
853
7955
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
-1.9e-02
1.0e-01
6.4e-01
2.2e+00
3.3e-01
2.7e-01
4.1e-02
cases:5.25%
controls:5.34%
cases:5.25%
controls:4.75%
cases:1.60%
controls:0.85%
cases:0.68%
controls:0.07%
cases:1.14%
controls:0.82%
cases:6.30%
controls:4.88%
cases:11.27%
controls:10.86%
46
434
831
7692
46
386
831
7740
14
69
863
8057
6
6
871
8120
10
67
867
8058
55
395
818
7692
97
865
764
7098
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
-2.4e-02
9.9e-02
6.4e-01
2.2e+00
3.3e-01
2.7e-01
4.0e-02
cases:5.25%
controls:5.37%
cases:5.25%
controls:4.77%
cases:1.60%
controls:0.85%
cases:0.68%
controls:0.07%
cases:1.14%
controls:0.82%
cases:6.30%
controls:4.88%
cases:11.27%
controls:10.88%
46
436
831
7690
46
388
831
7738
14
69
863
8057
6
6
871
8120
10
67
867
8058
55
395
818
7692
97
866
764
7097
Laparoscopy and sterilization
1412 [2000100157]
2.2e+00
—
—
—
—
—
—
cases:0.68%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
6
6
871
8120
—
—
—
—
—
—
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
-1.9e-02
1.0e-01
6.4e-01
2.2e+00
3.3e-01
2.7e-01
4.1e-02
cases:5.25%
controls:5.34%
cases:5.25%
controls:4.76%
cases:1.60%
controls:0.85%
cases:0.68%
controls:0.07%
cases:1.14%
controls:0.82%
cases:6.30%
controls:4.87%
cases:11.27%
controls:10.86%
46
434
831
7692
46
387
831
7739
14
69
863
8057
6
6
871
8120
10
67
867
8058
55
394
818
7693
97
865
764
7098
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
—
2.2e+00
—
—
—
—
6.5e-01
—
—
cases:0.68%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.43%
—
6
6
871
8120
—
—
—
—
7
34
854
7929
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
-1.9e-02
1.0e-01
6.4e-01
2.2e+00
3.3e-01
2.7e-01
4.1e-02
cases:5.25%
controls:5.34%
cases:5.25%
controls:4.76%
cases:1.60%
controls:0.85%
cases:0.68%
controls:0.07%
cases:1.14%
controls:0.82%
cases:6.30%
controls:4.88%
cases:11.27%
controls:10.86%
46
434
831
7692
46
387
831
7739
14
69
863
8057
6
6
871
8120
10
67
867
8058
55
395
818
7692
97
865
764
7098
Paraesthesia of skin
R20.2 [45568120]
—
2.2e+00
—
—
—
—
1.7e+00
—
—
cases:0.68%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.13%
—
6
6
871
8120
—
—
—
—
6
10
855
7953
Leukocytes [#/volume] in Blood
26464-8 [3010813]
-2.2e-02
1.1e-01
6.2e-01
2.2e+00
3.3e-01
2.7e-01
4.0e-02
cases:5.25%
controls:5.35%
cases:5.25%
controls:4.74%
cases:1.60%
controls:0.86%
cases:0.68%
controls:0.07%
cases:1.14%
controls:0.82%
cases:6.30%
controls:4.87%
cases:11.27%
controls:10.88%
46
435
831
7691
46
385
831
7741
14
70
863
8056
6
6
871
8120
10
67
867
8058
55
394
818
7693
97
866
764
7097
MCH [Entitic mass]
28539-5 [3035941]
-1.9e-02
1.0e-01
6.4e-01
2.2e+00
3.3e-01
2.7e-01
4.2e-02
cases:5.25%
controls:5.34%
cases:5.25%
controls:4.75%
cases:1.60%
controls:0.85%
cases:0.68%
controls:0.07%
cases:1.14%
controls:0.82%
cases:6.30%
controls:4.86%
cases:11.27%
controls:10.85%
46
434
831
7692
46
386
831
7740
14
69
863
8057
6
6
871
8120
10
67
867
8058
55
393
818
7694
97
864
764
7099
Platelets [#/volume] in Blood
26515-7 [3007461]
-1.4e-02
1.0e-01
6.4e-01
2.2e+00
3.3e-01
2.8e-01
4.5e-02
cases:5.25%
controls:5.32%
cases:5.25%
controls:4.75%
cases:1.60%
controls:0.85%
cases:0.68%
controls:0.07%
cases:1.14%
controls:0.82%
cases:6.30%
controls:4.85%
cases:11.27%
controls:10.83%
46
432
831
7694
46
386
831
7740
14
69
863
8057
6
6
871
8120
10
67
867
8058
55
392
818
7695
97
862
764
7101
Bilateral
ZXA10 [2001311348]
1.5e-01
—
—
—
—
2.2e+00
4.2e-01
cases:0.68%
controls:0.59%
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.07%
cases:1.16%
controls:0.77%
6
48
871
8078
—
—
—
—
6
6
867
8081
10
61
851
7902
Urethrocystoscopy
1530 [2000100185]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.08%
—
—
—
—
—
—
6
6
855
7957
Physiologic investigation of micturition
XKD06 [2001306098]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.08%
—
—
—
—
—
—
6
6
855
7957
Erythrocytes [Presence] in Urine
33051-4 [3045424]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.08%
—
—
—
—
—
—
6
6
855
7957
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2.8e-01
—
—
—
—
1.3e+00
8.3e-01
cases:0.91%
controls:0.69%
—
—
—
—
—
—
—
—
cases:1.37%
controls:0.37%
cases:2.44%
controls:1.08%
8
56
869
8070
—
—
—
—
12
30
861
8057
21
86
840
7877
Hip X-ray examination
NF1AA [2001307894]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.14%
—
—
—
—
—
—
10
11
851
7952
Exploration or removal of diskusprolapse
9211 [2000101463]
—
—
—
—
—
1.0e+50
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.00%
cases:1.16%
controls:0.14%
—
—
—
—
—
5
0
868
8087
10
11
851
7952
Ganglion
M67.4 [45582222]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.11%
—
—
—
—
—
—
8
9
853
7954
Polyarthrosis, unspecified
M15.9 [45543481]
2.1e+00
—
—
—
—
—
1.7e+00
cases:0.80%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.13%
7
8
870
8118
—
—
—
—
—
6
10
855
7953
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
1.1e+00
2.1e+00
—
—
—
2.0e+00
1.0e+00
cases:0.80%
controls:0.26%
cases:0.68%
controls:0.09%
—
—
—
—
—
—
cases:0.57%
controls:0.07%
cases:0.70%
controls:0.25%
7
21
870
8105
6
7
871
8119
—
—
—
5
6
868
8081
6
20
855
7943
Polyuria
R35 [45539331]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.09%
—
—
—
—
—
—
6
7
855
7956
Medical doctor
Z2221 [2001311556]
3.3e-01
9.1e-01
-1.0e+50
1.0e+50
—
1.2e+00
8.6e-01
cases:2.05%
controls:1.49%
cases:1.48%
controls:0.60%
cases:0.00%
controls:0.10%
cases:0.91%
controls:0.00%
—
—
cases:1.83%
controls:0.57%
cases:3.37%
controls:1.46%
18
121
859
8005
13
49
864
8077
0
8
877
8118
8
0
869
8126
—
16
46
857
8041
29
116
832
7847
Other specified urinary incontinence
N39.4 [45577525]
2.0e+00
—
—
—
—
—
1.2e+00
cases:0.80%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.21%
7
9
870
8117
—
—
—
—
—
6
17
855
7946
Exposure to other specified factors
X58 [45756411]
1.2e+00
2.0e+00
—
—
—
—
8.1e-01
cases:0.91%
controls:0.27%
cases:0.80%
controls:0.11%
—
—
—
—
—
—
—
—
cases:1.39%
controls:0.63%
8
22
869
8104
7
9
870
8117
—
—
—
—
12
50
849
7913
Supine thorax X-ray examination
GD1QA [2001303648]
6.6e-01
1.8e+00
—
—
—
2.0e+00
4.6e-01
cases:0.57%
controls:0.30%
cases:0.68%
controls:0.11%
—
—
—
—
—
—
cases:0.80%
controls:0.11%
cases:0.93%
controls:0.59%
5
24
872
8102
6
9
871
8117
—
—
—
7
9
866
8078
8
47
853
7916
Mechanical complication of internal joint prosthesis
T84.0 [45570736]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.11%
—
—
—
—
—
—
7
9
854
7954
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
-4.3e-02
8.4e-01
—
—
—
1.9e+00
5.3e-01
cases:0.68%
controls:0.71%
cases:0.57%
controls:0.25%
—
—
—
—
—
—
cases:1.37%
controls:0.20%
cases:1.63%
controls:0.97%
6
58
871
8068
5
20
872
8106
—
—
—
12
16
861
8071
14
77
847
7886
Impingement syndrome of shoulder
M75.4 [45553266]
1.9e+00
—
—
—
—
—
—
cases:1.03%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
9
12
868
8114
—
—
—
—
—
—
flumetasone and antiinfectives
S02CA02 [21605174]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.14%
—
—
—
—
—
—
8
11
853
7952
paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]
9.3e-01
1.2e+00
—
—
—
1.0e+00
9.8e-01
cases:3.19%
controls:1.28%
cases:1.14%
controls:0.36%
—
—
—
—
—
—
cases:0.80%
controls:0.28%
cases:3.14%
controls:1.21%
28
104
849
8022
10
29
867
8097
—
—
—
7
23
866
8064
27
96
834
7867
Removal of sutures
SPAT1153 [2001700254]
1.1e+00
1.2e+00
-1.0e+50
—
—
7.0e-01
7.9e-01
cases:2.28%
controls:0.80%
cases:1.14%
controls:0.36%
cases:0.00%
controls:0.06%
—
—
—
—
cases:0.57%
controls:0.28%
cases:2.67%
controls:1.23%
20
65
857
8061
10
29
867
8097
0
5
877
8121
—
—
5
23
868
8064
23
98
838
7865
Dysphagia
R13 [45573013]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.15%
—
—
—
—
—
—
8
12
853
7951
Abdominal pain localized other
D06 [2002000305]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.15%
—
—
—
—
—
—
8
12
853
7951
orphenadrine, combinations
M03BC51 [21604113]
9.0e-01
1.4e+00
—
—
—
1.1e+00
9.1e-01
cases:2.62%
controls:1.08%
cases:1.14%
controls:0.30%
—
—
—
—
—
—
cases:0.80%
controls:0.27%
cases:2.67%
controls:1.09%
23
88
854
8038
10
24
867
8102
—
—
—
7
22
866
8065
23
87
838
7876
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
8.4e-01
—
—
—
—
—
1.8e+00
cases:0.68%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.21%
6
24
871
8102
—
—
—
—
—
11
17
850
7946
mirtazapine; oral
N06AX11 [21604740]
5.3e-01
6.9e-01
—
—
1.3e+00
1.1e+00
7.2e-01
cases:2.74%
controls:1.64%
cases:1.71%
controls:0.86%
—
—
—
—
cases:0.80%
controls:0.21%
cases:2.29%
controls:0.79%
cases:4.41%
controls:2.20%
24
133
853
7993
15
70
862
8056
—
—
7
17
870
8108
20
64
853
8023
38
175
823
7788
Snapping jaw
K07.60 [2000502791]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.14%
—
—
—
—
—
—
7
11
854
7952
More than three and less than five hours
ZXE20 [2001311408]
5.4e-01
1.7e+00
—
—
—
—
1.2e+00
cases:0.57%
controls:0.33%
cases:0.91%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.28%
5
27
872
8099
8
13
869
8113
—
—
—
—
8
22
853
7941
Shoulder X-ray examination without contrast
NB1AA [2001307225]
—
—
—
—
—
—
1.7e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.19%
—
—
—
—
—
—
9
15
852
7948
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
7.5e-01
—
—
—
—
—
1.7e+00
cases:0.57%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.21%
5
22
872
8104
—
—
—
—
—
10
17
851
7946
FEV1/FVC
19926-5 [3011505]
7.5e-01
—
—
—
—
—
1.7e+00
cases:0.57%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.21%
5
22
872
8104
—
—
—
—
—
10
17
851
7946
FEV1
20150-9 [3024653]
7.5e-01
—
—
—
—
—
1.7e+00
cases:0.57%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.21%
5
22
872
8104
—
—
—
—
—
10
17
851
7946
Hip symptom/complaint
L13 [2002000637]
1.7e+00
1.6e+00
—
—
—
—
7.4e-01
cases:1.25%
controls:0.23%
cases:0.68%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.62%
11
19
866
8107
6
11
871
8115
—
—
—
—
11
49
850
7914
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
7.6e-01
7.1e-01
—
—
1.8e+00
9.4e-01
9.2e-01
cases:4.68%
controls:2.24%
cases:1.37%
controls:0.68%
—
—
—
—
cases:0.68%
controls:0.11%
cases:1.72%
controls:0.68%
cases:4.65%
controls:1.90%
41
182
836
7944
12
55
865
8071
—
—
6
9
871
8116
15
55
858
8032
40
151
821
7812
Left side
ZXA05 [2001311347]
2.4e-01
1.1e+00
—
—
—
1.7e+00
5.3e-01
cases:1.14%
controls:0.90%
cases:0.91%
controls:0.32%
—
—
—
—
—
—
cases:1.37%
controls:0.26%
cases:1.86%
controls:1.11%
10
73
867
8053
8
26
869
8100
—
—
—
12
21
861
8066
16
88
845
7875
Office Visit
OMOP4822458 [581477]
5.6e-01
1.0e+00
—
1.0e+50
1.6e+00
7.3e-01
6.6e-01
cases:4.45%
controls:2.58%
cases:2.28%
controls:0.84%
—
—
cases:0.68%
controls:0.00%
cases:0.80%
controls:0.16%
cases:1.83%
controls:0.89%
cases:4.88%
controls:2.59%
39
210
838
7916
20
68
857
8058
—
6
0
871
8126
7
13
870
8112
16
72
857
8015
42
206
819
7757
Back symptom/complaint
L02 [2002000627]
1.7e+00
—
—
—
—
—
1.1e+00
cases:0.91%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.28%
8
14
869
8112
—
—
—
—
—
7
22
854
7941
Pain general/multiple sites
A01 [2002000142]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.23%
—
—
—
—
—
—
10
18
851
7945
cefalexin; oral
J01DB01 [21602870]
2.5e-01
5.6e-01
5.6e-01
—
1.1e+00
6.9e-01
4.0e-01
cases:12.31%
controls:9.82%
cases:5.13%
controls:3.00%
cases:0.68%
controls:0.39%
—
—
cases:0.91%
controls:0.32%
cases:6.30%
controls:3.28%
cases:14.75%
controls:10.37%
108
798
769
7328
45
244
832
7882
6
32
871
8094
—
8
26
869
8099
55
265
818
7822
127
826
734
7137
Sedation and analgesia
WX002 [2001310758]
7.3e-01
—
—
—
—
1.5e+00
1.6e+00
cases:0.91%
controls:0.44%
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.15%
cases:2.79%
controls:0.55%
8
36
869
8090
—
—
—
—
6
12
867
8075
24
44
837
7919
lactulose; oral
A06AD11 [21600571]
6.7e-01
—
—
—
—
1.6e+00
5.5e-01
cases:1.03%
controls:0.53%
—
—
—
—
—
—
—
—
cases:1.15%
controls:0.23%
cases:1.05%
controls:0.60%
9
43
868
8083
—
—
—
—
10
19
863
8068
9
48
852
7915
clidinium and psycholeptics
A03CA02 [21600204]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.24%
—
—
—
—
—
—
10
19
851
7944
Urgent procedure
ZXD05 [2001311386]
-4.4e-01
1.6e+00
—
—
—
—
6.9e-01
cases:0.91%
controls:1.40%
cases:1.60%
controls:0.33%
—
—
—
—
—
—
—
—
cases:2.32%
controls:1.18%
8
114
869
8012
14
27
863
8099
—
—
—
—
20
94
841
7869
Panorama tomography of teeth and jaws or similar X-ray examination
EB1HA [2001301913]
8.2e-01
9.4e-01
—
—
—
—
7.6e-01
cases:2.51%
controls:1.12%
cases:1.25%
controls:0.49%
—
—
—
—
—
—
—
—
cases:3.37%
controls:1.61%
22
91
855
8035
11
40
866
8086
—
—
—
—
29
128
832
7835
Small restoration
SFA00 [2001310357]
1.5e+00
—
—
—
—
—
8.4e-01
cases:1.37%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:0.45%
12
24
865
8102
—
—
—
—
—
9
36
852
7927
Right side
ZXA00 [2001311346]
7.5e-01
9.8e-01
—
—
—
1.5e+00
4.4e-01
cases:2.17%
controls:1.03%
cases:0.91%
controls:0.34%
—
—
—
—
—
—
cases:1.26%
controls:0.27%
cases:1.63%
controls:1.05%
19
84
858
8042
8
28
869
8098
—
—
—
11
22
862
8065
14
84
847
7879
Intravenous general anesthesia
WX404 [2001310807]
6.8e-01
1.5e+00
—
—
—
—
7.7e-01
cases:1.14%
controls:0.58%
cases:1.03%
controls:0.22%
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.70%
10
47
867
8079
9
18
868
8108
—
—
—
—
13
56
848
7907
Examination and observation for other specified reasons
Z04.8 [45552063]
5.8e-01
—
—
—
—
—
1.5e+00
cases:0.57%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.34%
5
26
872
8100
—
—
—
—
—
13
27
848
7936
Hand/finger symptom/complaint
L12 [2002000636]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.34%
—
—
—
—
—
—
13
27
848
7936
Cathetrisation of vein
TPH04 [2001309597]
8.2e-01
—
—
—
—
1.2e+00
1.5e+00
cases:1.14%
controls:0.50%
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.20%
cases:2.67%
controls:0.62%
10
41
867
8085
—
—
—
—
6
16
867
8071
23
49
838
7914
Infiltration anesthesia
WX110 [2001310767]
4.7e-01
3.9e-01
—
—
—
9.1e-01
5.7e-01
cases:5.02%
controls:3.20%
cases:2.28%
controls:1.56%
—
—
—
—
—
—
cases:4.01%
controls:1.66%
cases:8.83%
controls:5.19%
44
260
833
7866
20
127
857
7999
—
—
—
35
134
838
7953
76
413
785
7550
esomeprazole; oral, parenteral
A02BC05 [21600100]
6.7e-01
7.3e-01
—
—
—
4.9e-01
8.0e-01
cases:4.79%
controls:2.50%
cases:2.74%
controls:1.34%
—
—
—
—
—
—
cases:2.29%
controls:1.42%
cases:6.27%
controls:2.93%
42
203
835
7923
24
109
853
8017
—
—
—
20
115
853
7972
54
233
807
7730
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
1.0e+00
1.8e+00
—
—
—
—
1.5e+00
cases:0.57%
controls:0.21%
cases:0.57%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.30%
5
17
872
8109
5
8
872
8118
—
—
—
—
11
24
850
7939
clonazepam; oral, parenteral
N03AE01 [21604415]
1.0e+00
1.0e+00
—
—
-1.0e+50
1.4e+00
1.4e+00
cases:0.80%
controls:0.30%
cases:0.68%
controls:0.25%
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.92%
controls:0.23%
cases:1.63%
controls:0.39%
7
24
870
8102
6
20
871
8106
—
—
0
5
877
8120
8
19
865
8068
14
31
847
7932
Primary arthrosis of other joints
M19.0 [45601353]
1.3e+00
—
—
—
—
—
1.4e+00
cases:0.91%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.36%
8
21
869
8105
—
—
—
—
—
13
29
848
7934
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
1.0e+00
—
—
—
—
—
1.4e+00
cases:0.68%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.29%
6
20
871
8106
—
—
—
—
—
10
23
851
7940
rofecoxib; oral
M01AH02 [21603993]
2.1e-01
1.9e+00
—
—
—
1.8e+00
1.4e+00
cases:0.68%
controls:0.55%
cases:0.68%
controls:0.10%
—
—
—
—
—
—
cases:0.57%
controls:0.10%
cases:1.39%
controls:0.35%
6
45
871
8081
6
8
871
8118
—
—
—
5
8
868
8079
12
28
849
7935
Dyspnoea
R06.0 [45558449]
1.4e+00
—
—
—
—
—
-2.0e-01
cases:1.94%
controls:0.49%
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:1.13%
17
40
860
8086
—
—
—
—
—
8
90
853
7873
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
2.5e-01
1.4e+00
-1.0e+50
—
—
9.2e-01
8.3e-01
cases:0.91%
controls:0.71%
cases:1.25%
controls:0.32%
cases:0.00%
controls:0.06%
—
—
—
—
cases:0.80%
controls:0.32%
cases:2.32%
controls:1.03%
8
58
869
8068
11
26
866
8100
0
5
877
8121
—
—
7
26
866
8061
20
82
841
7881
Abdominal pain/cramps general
D01 [2002000300]
1.2e+00
—
—
—
—
—
1.4e+00
cases:0.57%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.33%
5
14
872
8112
—
—
—
—
—
11
26
850
7937
amitriptyline and psycholeptics
N06CA01 [21604789]
9.9e-01
1.1e+00
—
—
—
1.0e+00
1.4e+00
cases:1.48%
controls:0.55%
cases:1.03%
controls:0.34%
—
—
—
—
—
—
cases:0.69%
controls:0.25%
cases:1.86%
controls:0.48%
13
45
864
8081
9
28
868
8098
—
—
—
6
20
867
8067
16
38
845
7925
calcium (different salts in combination); oral
A12AA20 [21600872]
5.6e-01
7.1e-01
—
—
—
7.7e-01
5.9e-01
cases:2.96%
controls:1.72%
cases:2.62%
controls:1.30%
—
—
—
—
—
—
cases:3.09%
controls:1.46%
cases:5.23%
controls:2.98%
26
140
851
7986
23
106
854
8020
—
—
—
27
118
846
7969
45
237
816
7726
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
9.3e-01
7.3e-01
—
—
—
1.4e+00
8.2e-01
cases:1.82%
controls:0.73%
cases:0.68%
controls:0.33%
—
—
—
—
—
—
cases:1.37%
controls:0.36%
cases:2.44%
controls:1.09%
16
59
861
8067
6
27
871
8099
—
—
—
12
29
861
8058
21
87
840
7876
diclofenac
D11AX18 [21602355]
1.4e+00
1.5e+00
—
—
—
—
5.8e-01
cases:1.60%
controls:0.42%
cases:0.68%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.65%
14
34
863
8092
6
12
871
8114
—
—
—
—
10
52
851
7911
diclofenac; ointment
M02AA15 [21604051]
1.4e+00
1.5e+00
—
—
—
—
5.8e-01
cases:1.60%
controls:0.42%
cases:0.68%
controls:0.15%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.65%
14
34
863
8092
6
12
871
8114
—
—
—
—
10
52
851
7911
pantoprazole; oral, parenteral
A02BC02 [21600097]
5.8e-01
5.8e-01
—
—
—
7.7e-01
4.2e-01
cases:6.27%
controls:3.62%
cases:3.76%
controls:2.14%
—
—
—
—
—
—
cases:4.24%
controls:2.00%
cases:8.48%
controls:5.75%
55
294
822
7832
33
174
844
7952
—
—
—
37
162
836
7925
73
458
788
7505
ketoprofen; ointment
M02AA10 [21604046]
5.1e-01
—
—
—
—
—
1.3e+00
cases:1.14%
controls:0.69%
—
—
—
—
—
—
—
—
—
—
cases:1.86%
controls:0.51%
10
56
867
8070
—
—
—
—
—
16
41
845
7922
Cystoscopy
UKC02 [2001306005]
1.3e+00
—
—
—
—
1.2e+00
1.2e+00
cases:1.03%
controls:0.27%
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.20%
cases:1.39%
controls:0.41%
9
22
868
8104
—
—
—
—
6
16
867
8071
12
33
849
7930
Other specified special examinations
Z01.8 [45581003]
6.2e-01
9.5e-01
—
—
—
1.0e+00
1.2e+00
cases:1.14%
controls:0.62%
cases:0.57%
controls:0.22%
—
—
—
—
—
—
cases:0.69%
controls:0.25%
cases:2.90%
controls:0.88%
10
50
867
8076
5
18
872
8108
—
—
—
6
20
867
8067
25
70
836
7893
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
9.4e-01
1.0e+00
—
—
—
—
1.2e+00
cases:1.37%
controls:0.54%
cases:0.57%
controls:0.21%
—
—
—
—
—
—
—
—
cases:1.74%
controls:0.54%
12
44
865
8082
5
17
872
8109
—
—
—
—
15
43
846
7920
salbutamol; inhalant
R03AC02 [21603256]
6.5e-01
6.7e-01
—
—
—
3.9e-01
5.2e-01
cases:6.61%
controls:3.58%
cases:3.08%
controls:1.60%
—
—
—
—
—
—
cases:2.75%
controls:1.88%
cases:7.67%
controls:4.72%
58
291
819
7835
27
130
850
7996
—
—
—
24
152
849
7935
66
376
795
7587
venlafaxine; oral
N06AX16 [21604745]
6.2e-01
7.5e-01
—
—
—
1.3e+00
1.2e+00
cases:1.14%
controls:0.62%
cases:0.57%
controls:0.27%
—
—
—
—
—
—
cases:1.26%
controls:0.36%
cases:2.21%
controls:0.70%
10
50
867
8076
5
22
872
8104
—
—
—
11
29
862
8058
19
56
842
7907
quetiapine; oral
N05AH04 [21604544]
8.5e-01
9.8e-01
—
—
1.6e+00
1.1e+00
4.1e-01
cases:1.25%
controls:0.54%
cases:1.14%
controls:0.43%
—
—
—
—
cases:0.57%
controls:0.11%
cases:1.60%
controls:0.52%
cases:1.39%
controls:0.93%
11
44
866
8082
10
35
867
8091
—
—
5
9
872
8116
14
42
859
8045
12
74
849
7889
Dentistry
C5 [903277]
1.2e-01
—
—
—
—
—
1.1e+00
cases:0.57%
controls:0.50%
—
—
—
—
—
—
—
—
—
—
cases:1.63%
controls:0.53%
5
41
872
8085
—
—
—
—
—
14
42
847
7921
Ultrasound examination of lower leg veins
PH2AE [2001309451]
1.5e+00
—
—
—
—
—
1.1e+00
cases:0.80%
controls:0.17%
—
—
—
—
—
—
—
—
—
—
cases:1.51%
controls:0.49%
7
14
870
8112
—
—
—
—
—
13
39
848
7924
Urology
34 [38004474]
6.6e-01
4.0e-01
—
—
—
1.1e+00
6.9e-01
cases:2.17%
controls:1.13%
cases:1.03%
controls:0.69%
—
—
—
—
—
—
cases:2.18%
controls:0.72%
cases:3.25%
controls:1.66%
19
92
858
8034
9
56
868
8070
—
—
—
19
58
854
8029
28
132
833
7831
Pain localized to other parts of lower abdomen
R10.3 [45534426]
8.0e-01
1.3e+00
—
—
—
—
1.1e+00
cases:1.71%
controls:0.78%
cases:0.57%
controls:0.16%
—
—
—
—
—
—
—
—
cases:3.25%
controls:1.09%
15
63
862
8063
5
13
872
8113
—
—
—
—
28
87
833
7876
tranexamic acid; oral, parenteral
B02AA02 [21601036]
1.1e+00
—
—
—
-1.0e+50
—
-1.6e-01
cases:1.94%
controls:0.68%
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
cases:0.58%
controls:0.68%
17
55
860
8071
—
—
—
0
5
877
8120
—
5
54
856
7909
Rheumatology
66 [38004491]
8.0e-01
3.7e-01
—
—
—
8.2e-01
1.1e+00
cases:1.71%
controls:0.78%
cases:0.80%
controls:0.55%
—
—
—
—
—
—
cases:1.26%
controls:0.56%
cases:3.14%
controls:1.11%
15
63
862
8063
7
45
870
8081
—
—
—
11
45
862
8042
27
88
834
7875
nimesulide; oral
M01AX17 [21604007]
1.1e+00
1.4e+00
—
—
—
1.0e+00
6.0e-01
cases:2.05%
controls:0.73%
cases:0.68%
controls:0.17%
—
—
—
—
—
—
cases:0.57%
controls:0.21%
cases:1.28%
controls:0.70%
18
59
859
8067
6
14
871
8112
—
—
—
5
17
868
8070
11
56
850
7907
celecoxib
L01XX33 [21603805]
1.0e+00
1.4e+00
—
—
—
7.9e-01
4.4e-01
cases:1.94%
controls:0.69%
cases:1.03%
controls:0.25%
—
—
—
—
—
—
cases:0.57%
controls:0.26%
cases:1.51%
controls:0.98%
17
56
860
8070
9
20
868
8106
—
—
—
5
21
868
8066
13
78
848
7885
celecoxib; oral
M01AH01 [21603992]
1.0e+00
1.4e+00
—
—
—
7.9e-01
4.4e-01
cases:1.94%
controls:0.69%
cases:1.03%
controls:0.25%
—
—
—
—
—
—
cases:0.57%
controls:0.26%
cases:1.51%
controls:0.98%
17
56
860
8070
9
20
868
8106
—
—
—
5
21
868
8066
13
78
848
7885
Osmolality of Urine
2695-5 [3026782]
-1.5e-01
—
-1.0e+50
—
—
—
1.0e+00
cases:0.57%
controls:0.66%
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
cases:1.86%
controls:0.68%
5
54
872
8072
—
0
5
877
8121
—
—
—
16
54
845
7909
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
6.4e-01
—
—
—
—
—
9.8e-01
cases:1.82%
controls:0.97%
—
—
—
—
—
—
—
—
—
—
cases:3.25%
controls:1.24%
16
79
861
8047
—
—
—
—
—
28
99
833
7864
Bacteria identified in Urine by Culture
630-4 [3026008]
4.3e-02
4.7e-01
—
—
—
3.7e-01
9.7e-01
cases:0.91%
controls:0.87%
cases:0.68%
controls:0.43%
—
—
—
—
—
—
cases:0.57%
controls:0.40%
cases:3.48%
controls:1.34%
8
71
869
8055
6
35
871
8091
—
—
—
5
32
868
8055
30
107
831
7856
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
9.7e-01
—
—
—
—
9.6e-01
4.5e-01
cases:2.05%
controls:0.79%
—
—
—
—
—
—
—
—
cases:0.80%
controls:0.31%
cases:1.97%
controls:1.27%
18
64
859
8062
—
—
—
—
7
25
866
8062
17
101
844
7862
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
5.8e-01
6.6e-01
-1.0e+50
—
—
7.3e-01
9.5e-01
cases:2.96%
controls:1.69%
cases:1.14%
controls:0.59%
cases:0.00%
controls:0.06%
—
—
—
—
cases:1.15%
controls:0.56%
cases:4.53%
controls:1.80%
26
137
851
7989
10
48
867
8078
0
5
877
8121
—
—
10
45
863
8042
39
143
822
7820
Atrial fibrillation and flutter
I48 [45596206]
5.7e-01
8.0e-01
—
—
—
1.0e+00
9.5e-01
cases:1.71%
controls:0.97%
cases:1.25%
controls:0.57%
—
—
—
—
—
—
cases:1.49%
controls:0.53%
cases:3.37%
controls:1.33%
15
79
862
8047
11
46
866
8080
—
—
—
13
43
860
8044
29
106
832
7857
Spinalanesthesia
WX320 [2001310799]
8.5e-01
—
—
—
—
1.2e+00
9.4e-01
cases:1.82%
controls:0.79%
—
—
—
—
—
—
—
—
cases:0.69%
controls:0.20%
cases:2.09%
controls:0.83%
16
64
861
8062
—
—
—
—
6
16
867
8071
18
66
843
7897
estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 [21602517]
1.6e-01
1.9e-01
-2.7e-01
—
9.2e-01
1.7e-01
3.5e-01
cases:6.16%
controls:5.29%
cases:4.45%
controls:3.72%
cases:0.80%
controls:1.05%
—
—
cases:2.05%
controls:0.82%
cases:4.93%
controls:4.18%
cases:9.99%
controls:7.23%
54
430
823
7696
39
302
838
7824
7
85
870
8041
—
18
67
859
8058
43
338
830
7749
86
576
775
7387
Coloscopy
UJF32 [2001305029]
3.1e-01
8.4e-01
—
—
—
—
9.1e-01
cases:1.14%
controls:0.84%
cases:0.57%
controls:0.25%
—
—
—
—
—
—
—
—
cases:2.90%
controls:1.19%
10
68
867
8058
5
20
872
8106
—
—
—
—
25
95
836
7868
Asthma, unspecified
J45.9 [45562456]
9.3e-01
8.0e-01
—
—
—
1.1e+00
9.0e-01
cases:1.48%
controls:0.59%
cases:0.68%
controls:0.31%
—
—
—
—
—
—
cases:0.92%
controls:0.32%
cases:2.44%
controls:1.00%
13
48
864
8078
6
25
871
8101
—
—
—
8
26
865
8061
21
80
840
7883
doxycycline; oral, parenteral
J01AA02 [21602800]
4.8e-01
1.4e-01
-1.0e+50
—
—
5.1e-02
4.2e-01
cases:11.17%
controls:7.24%
cases:2.28%
controls:1.99%
cases:0.00%
controls:0.26%
—
—
—
—
cases:2.52%
controls:2.40%
cases:9.64%
controls:6.57%
98
588
779
7538
20
162
857
7964
0
21
877
8105
—
—
22
194
851
7893
83
523
778
7440
Obstetrics / Gynecology
16 [38004461]
4.4e-01
2.1e-02
—
—
—
1.2e-01
4.5e-01
cases:12.43%
controls:8.38%
cases:2.85%
controls:2.79%
—
—
—
—
—
—
cases:2.86%
controls:2.55%
cases:11.27%
controls:7.50%
109
681
768
7445
25
227
852
7899
—
—
—
25
206
848
7881
97
597
764
7366
piroxicam; ointment
M02AA07 [21604043]
5.1e-01
8.2e-01
—
—
—
8.1e-01
8.6e-01
cases:3.31%
controls:2.02%
cases:1.14%
controls:0.50%
—
—
—
—
—
—
cases:0.92%
controls:0.41%
cases:3.60%
controls:1.56%
29
164
848
7962
10
41
867
8085
—
—
—
8
33
865
8054
31
124
830
7839
Periodontal treatment by dental hygienist
SDE02 [2001310350]
-3.2e-01
—
—
—
—
—
8.5e-01
cases:0.68%
controls:0.94%
—
—
—
—
—
—
—
—
—
—
cases:2.56%
controls:1.11%
6
76
871
8050
—
—
—
—
—
22
88
839
7875
piroxicam; oral, parenteral, rectal
M01AC01 [21603961]
5.6e-01
7.8e-01
—
—
—
8.7e-01
8.4e-01
cases:4.10%
controls:2.39%
cases:1.25%
controls:0.58%
—
—
—
—
—
—
cases:1.26%
controls:0.53%
cases:4.07%
controls:1.80%
36
194
841
7932
11
47
866
8079
—
—
—
11
43
862
8044
35
143
826
7820
Supplier / Service Provider
OMOP5117446 [33004]
-2.9e+00
-2.3e+00
—
—
—
2.6e+00
3.4e+00
cases:4.90%
controls:48.54%
cases:1.82%
controls:15.04%
—
—
—
—
—
—
cases:1.26%
controls:0.10%
cases:6.27%
controls:0.21%
43
3944
834
4182
16
1222
861
6904
—
—
—
11
8
862
8079
54
17
807
7946
Gastroenterology
10 [38004455]
6.7e-01
4.9e-01
—
—
-1.0e+50
9.0e-01
8.3e-01
cases:1.94%
controls:1.00%
cases:0.68%
controls:0.42%
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.03%
controls:0.42%
cases:3.48%
controls:1.56%
17
81
860
8045
6
34
871
8092
—
—
0
5
877
8120
9
34
864
8053
30
124
831
7839
Otolaryngology
4 [38004449]
4.5e-01
2.8e-01
—
—
—
5.7e-01
7.7e-01
cases:6.16%
controls:4.00%
cases:1.94%
controls:1.48%
—
—
—
—
—
—
cases:2.63%
controls:1.51%
cases:8.71%
controls:4.22%
54
325
823
7801
17
120
860
8006
—
—
—
23
122
850
7965
75
336
786
7627
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
3.0e-01
4.4e-01
—
—
—
8.7e-01
7.4e-01
cases:1.14%
controls:0.85%
cases:0.91%
controls:0.59%
—
—
—
—
—
—
cases:1.15%
controls:0.48%
cases:3.37%
controls:1.63%
10
69
867
8057
8
48
869
8078
—
—
—
10
39
863
8048
29
130
832
7833
Extended examination of mouth
SAA03 [2001310276]
9.2e-02
—
-1.0e+50
—
-1.0e+50
4.8e-01
7.4e-01
cases:1.71%
controls:1.56%
—
—
cases:0.00%
controls:0.07%
—
—
cases:0.00%
controls:0.06%
cases:0.92%
controls:0.57%
cases:4.41%
controls:2.16%
15
127
862
7999
—
0
6
877
8120
—
0
5
877
8120
8
46
865
8041
38
172
823
7791
INR in Blood by Coagulation assay
34714-6 [3032080]
6.3e-01
4.9e-01
—
—
—
9.6e-01
6.8e-01
cases:2.17%
controls:1.17%
cases:1.14%
controls:0.70%
—
—
—
—
—
—
cases:1.60%
controls:0.62%
cases:3.72%
controls:1.92%
19
95
858
8031
10
57
867
8069
—
—
—
14
50
859
8037
32
153
829
7810
fluconazole; oral, parenteral
J02AC01 [21603080]
3.5e-01
5.1e-01
—
—
—
5.4e-01
6.8e-01
cases:4.10%
controls:2.93%
cases:1.71%
controls:1.03%
—
—
—
—
—
—
cases:1.60%
controls:0.94%
cases:5.23%
controls:2.73%
36
238
841
7888
15
84
862
8042
—
—
—
14
76
859
8011
45
217
816
7746
prednisolone
A07EA01 [21600653]
4.2e-01
7.0e-01
—
—
—
7.5e-01
6.6e-01
cases:4.10%
controls:2.74%
cases:2.62%
controls:1.32%
—
—
—
—
—
—
cases:2.63%
controls:1.26%
cases:6.74%
controls:3.59%
36
223
841
7903
23
107
854
8019
—
—
—
23
102
850
7985
58
286
803
7677
prednisolone; oral, parenteral
H02AB06 [21602734]
4.2e-01
7.0e-01
—
—
—
7.5e-01
6.6e-01
cases:4.10%
controls:2.73%
cases:2.62%
controls:1.32%
—
—
—
—
—
—
cases:2.63%
controls:1.26%
cases:6.74%
controls:3.59%
36
222
841
7904
23
107
854
8019
—
—
—
23
102
850
7985
58
286
803
7677
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
1.5e-01
1.1e-01
1.0e+00
—
—
6.4e-01
2.8e-01
cases:4.10%
controls:3.54%
cases:2.74%
controls:2.46%
cases:0.68%
controls:0.25%
—
—
—
—
cases:4.24%
controls:2.29%
cases:9.41%
controls:7.27%
36
288
841
7838
24
200
853
7926
6
20
871
8106
—
—
37
185
836
7902
81
579
780
7384
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
3.7e-01
2.5e-01
—
—
—
2.9e-01
6.1e-01
cases:3.08%
controls:2.14%
cases:1.48%
controls:1.16%
—
—
—
—
—
—
cases:1.60%
controls:1.20%
cases:6.39%
controls:3.57%
27
174
850
7952
13
94
864
8032
—
—
—
14
97
859
7990
55
284
806
7679
Cardiology
6 [38004451]
4.4e-01
8.2e-02
—
—
—
7.4e-01
5.9e-01
cases:3.08%
controls:2.01%
cases:1.25%
controls:1.16%
—
—
—
—
—
—
cases:1.72%
controls:0.83%
cases:4.76%
controls:2.69%
27
163
850
7963
11
94
866
8032
—
—
—
15
67
858
8020
41
214
820
7749
amoxicillin; oral, parenteral
J01CA04 [21602823]
2.4e-01
3.5e-01
—
—
—
5.5e-01
5.4e-01
cases:9.12%
controls:7.31%
cases:3.42%
controls:2.44%
—
—
—
—
—
—
cases:3.55%
controls:2.09%
cases:12.08%
controls:7.40%
80
594
797
7532
30
198
847
7928
—
—
—
31
169
842
7918
104
589
757
7374
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
3.0e-02
6.0e-01
9.5e-01
—
—
3.9e-01
5.1e-01
cases:2.62%
controls:2.55%
cases:2.74%
controls:1.53%
cases:0.57%
controls:0.22%
—
—
—
—
cases:2.29%
controls:1.56%
cases:6.97%
controls:4.32%
23
207
854
7919
24
124
853
8002
5
18
872
8108
—
—
20
126
853
7961
60
344
801
7619
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.8e-02
1.3e-01
7.0e-01
2.2e+00
5.8e-01
2.9e-01
5.7e-02
cases:5.02%
controls:4.89%
cases:4.68%
controls:4.15%
cases:1.48%
controls:0.74%
cases:0.57%
controls:0.06%
cases:1.14%
controls:0.64%
cases:5.73%
controls:4.33%
cases:10.34%
controls:9.82%
44
397
833
7729
41
337
836
7789
13
60
864
8066
5
5
872
8121
10
52
867
8073
50
350
823
7737
89
782
772
7181
Diseases of pulp and periapical tissues, Periapical abscess
52250 [2000302964]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
0
8
861
7955
Blepharitis
H01.0 [45533180]
-1.0e+50
-1.0e+50
—
—
—
—
7.9e-01
cases:0.00%
controls:0.06%
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.26%
0
5
877
8121
0
5
877
8121
—
—
—
—
5
21
856
7942
Emergency visit or other similar visit involving procedures
WYA05 [2001310871]
2.6e-01
5.4e-01
-1.0e+50
—
—
8.5e-01
5.5e-01
cases:2.62%
controls:2.04%
cases:1.37%
controls:0.80%
cases:0.00%
controls:0.15%
—
—
—
—
cases:1.83%
controls:0.79%
cases:5.34%
controls:3.15%
23
166
854
7960
12
65
865
8061
0
12
877
8114
—
—
16
64
857
8023
46
251
815
7712
Cardiac arrhythmia, unspecified
I49.9 [45581778]
—
—
—
—
—
—
1.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.28%
controls:0.46%
—
—
—
—
—
—
11
37
850
7926
Other benign neoplasm of uterus, Papiloma, polyp
21900 [2000301202]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
877
8120
—
—
—
—
—
—
Pneumonia, unspecified
J18.9 [45601123]
3.6e-01
—
-1.0e+50
—
—
—
4.9e-01
cases:0.68%
controls:0.48%
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
cases:1.63%
controls:1.00%
6
39
871
8087
—
0
5
877
8121
—
—
—
14
80
847
7883
Shoulder syndrome
L92 [2002000711]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
0
5
861
7958
papaverine, combinations
G04BE52 [21602656]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
877
8120
—
—
—
—
—
—
Hyperlipidaemia, unspecified
E78.5 [45537986]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
0
7
877
8119
—
—
—
—
—
Detailed ultrasound examination of fetus including color doppler method
MA2DE [2001306835]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
cases:0.00%
controls:0.07%
—
—
—
0
7
877
8119
—
—
—
0
6
873
8081
—
Tooth plaque
K03.66 [2000502691]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
0
5
877
8121
—
—
—
—
—
metronidazole; oral, rectal
P01AB01 [21604857]
5.8e-01
4.2e-01
—
—
-1.0e+50
6.8e-01
5.6e-01
cases:3.65%
controls:2.08%
cases:0.91%
controls:0.60%
—
—
—
—
cases:0.00%
controls:0.11%
cases:1.26%
controls:0.64%
cases:4.18%
controls:2.42%
32
169
845
7957
8
49
869
8077
—
—
0
9
877
8116
11
52
862
8035
36
193
825
7770
phenylpropanolamine, combinations; oral
R01BA51 [21603212]
5.0e-01
—
—
—
-1.0e+50
7.5e-01
6.0e-01
cases:1.71%
controls:1.05%
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.57%
controls:0.27%
cases:1.16%
controls:0.64%
15
85
862
8041
—
—
—
0
5
877
8120
5
22
868
8065
10
51
851
7912
Assessment of need for psychiatric treatment
IAA01 [2001304011]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
0
7
861
7956
Diabetes mellitus screening
171183004 [4064918]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
0
5
877
8121
—
—
—
—
—
0
7
861
7956
terbutaline; inhalant
R03AC03 [21603257]
4.8e-01
3.8e-01
—
—
—
4.9e-01
7.0e-01
cases:1.60%
controls:1.00%
cases:0.68%
controls:0.47%
—
—
—
—
—
—
cases:0.69%
controls:0.42%
cases:1.51%
controls:0.75%
14
81
863
8045
6
38
871
8088
—
—
—
6
34
867
8053
13
60
848
7903
Intravenous sedation or analgesia without general anesthesia
WX006 [2001310762]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
0
10
861
7953
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
877
8120
—
—
—
—
—
—
beclometasone; nasal
R01AD01 [21605043]
2.5e-01
—
—
—
—
—
—
cases:0.91%
controls:0.71%
—
—
—
—
—
—
—
—
—
—
—
—
8
58
869
8068
—
—
—
—
—
—
Skin symptom/complaint other
S29 [2002000993]
6.5e-01
—
—
—
—
—
2.3e-01
cases:0.68%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
cases:0.93%
controls:0.74%
6
29
871
8097
—
—
—
—
—
8
59
853
7904
Urinary tract infection, site not specified
N39.0 [45548665]
4.7e-01
—
—
—
—
—
4.6e-01
cases:0.57%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.51%
5
29
872
8097
—
—
—
—
—
7
41
854
7922
Hypertensive heart disease without (congestive) heart failure
I11.9 [45576863]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
0
5
873
8082
—
Cocaine [Presence] in Urine
3397-7 [3016879]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.12%
cases:0.00%
controls:0.09%
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
0
10
877
8116
0
7
877
8119
—
—
—
0
5
873
8082
—
Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
14756-1 [3015024]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
0
5
861
7958
hyoscyamine and psycholeptics
A03CB31 [21600218]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
877
8120
—
—
—
—
—
—
Sick sinus syndrome
I49.5 [45562354]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
877
8119
—
—
—
—
—
—
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: quitter
SMOKING-2-2-3 [2002330111]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
877
8118
—
—
—
—
—
—
Counselling and guidance related to nutrition and weight management
SPAT1306 [2001700407]
—
-1.0e+50
—
—
—
—
5.8e-01
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.33%
—
0
7
877
8119
—
—
—
—
5
26
856
7937
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
3.7e-01
3.6e-01
—
—
—
1.4e-01
3.2e-01
cases:3.88%
controls:2.71%
cases:2.51%
controls:1.76%
—
—
—
—
—
—
cases:2.06%
controls:1.79%
cases:5.92%
controls:4.38%
34
220
843
7906
22
143
855
7983
—
—
—
18
145
855
7942
51
349
810
7614
Bipolar affective disorder, unspecified
F31.9 [45571758]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
9
861
7954
tolfenamic acid; oral, rectal
M01AG02 [21603988]
4.4e-01
—
—
—
—
—
—
cases:1.14%
controls:0.74%
—
—
—
—
—
—
—
—
—
—
—
—
10
60
867
8066
—
—
—
—
—
—
Albumin [Mass/volume] in Urine
1754-1 [3012516]
6.2e-01
3.1e-01
-1.0e+50
—
—
1.2e-01
-3.8e-01
cases:1.37%
controls:0.74%
cases:0.68%
controls:0.50%
cases:0.00%
controls:0.06%
—
—
—
—
cases:0.57%
controls:0.51%
cases:1.28%
controls:1.86%
12
60
865
8066
6
41
871
8085
0
5
877
8121
—
—
5
41
868
8046
11
148
850
7815
Dorsalgia
M54 [45553203]
—
—
—
—
—
-1.0e+50
6.5e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
cases:0.81%
controls:0.43%
—
—
—
—
—
0
7
873
8080
7
34
854
7929
prazosin; oral
C02CA01 [21600411]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
0
8
861
7955
Benign neoplasm: Sigmoid colon
D12.5 [45552326]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.07%
—
—
0
6
877
8120
—
—
—
—
0
6
873
8081
—
oxycodone and naloxone; oral
N02AA55 [21604265]
1.4e+00
1.7e+00
—
—
—
—
1.0e+00
cases:0.91%
controls:0.23%
cases:0.68%
controls:0.12%
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.41%
8
19
869
8107
6
10
871
8116
—
—
—
—
10
33
851
7930
Person consulting for explanation of investigation findings
Z71.2 [45552100]
6.2e-02
—
—
—
—
8.1e-01
3.4e-01
cases:0.80%
controls:0.75%
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.41%
cases:1.63%
controls:1.17%
7
61
870
8065
—
—
—
—
8
33
865
8054
14
93
847
7870
Derangement of meniscus due to old tear or injury
M23.2 [45591779]
1.1e+00
—
—
—
—
—
7.2e-01
cases:0.57%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.34%
5
16
872
8110
—
—
—
—
—
6
27
855
7936
bisoprolol; oral
C07AB07 [21601689]
-4.2e-02
2.6e-02
—
—
2.9e-02
1.6e-01
2.5e-01
cases:3.53%
controls:3.68%
cases:3.42%
controls:3.33%
—
—
—
—
cases:0.91%
controls:0.89%
cases:3.89%
controls:3.34%
cases:6.27%
controls:4.94%
31
299
846
7827
30
271
847
7855
—
—
8
72
869
8053
34
270
839
7817
54
393
807
7570
Very extensive CT of head and brain
AA1CD [2001300114]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
0
6
861
7957
Demanding periodontal treatment
SDA04 [2001310329]
1.3e-01
—
—
—
—
—
-1.9e-01
cases:0.68%
controls:0.60%
—
—
—
—
—
—
—
—
—
—
cases:1.05%
controls:1.26%
6
49
871
8077
—
—
—
—
—
9
100
852
7863
tropicamide
S01FA06 [21605065]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
0
8
861
7955
Preventive sterilization, Legal sterilization, medical reasons (illness or physical injury)
Y4300 [2000306796]
1.4e+00
—
—
—
—
—
—
cases:0.57%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
5
12
872
8114
—
—
—
—
—
—
Benign neoplasm: Rectum
D12.8 [45595734]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
877
8121
—
—
—
—
—
—
nafarelin; nasal
H01CA02 [21602712]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.14%
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
0
11
877
8115
0
6
877
8120
—
—
—
—
0
5
861
7958
Radiotherapy of metastasis
WF049 [2001310705]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
0
5
861
7958
dexamethasone; oral, parenteral
H02AB02 [21602730]
2.5e-01
—
—
—
—
—
-3.0e-01
cases:0.57%
controls:0.44%
—
—
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.78%
5
36
872
8090
—
—
—
—
—
5
62
856
7901
Base excess in Arterial blood by calculation
1925-7 [3003396]
1.4e+00
—
—
—
—
—
—
cases:0.57%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
—
—
5
12
872
8114
—
—
—
—
—
—
Photography of fundus of eye
XCK10 [2001301381]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
—
0
11
877
8115
—
—
—
—
—
Spirometry at the office
SPAT1059 [2001700160]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.24%
—
—
—
—
—
—
0
19
861
7944
pH of Urine by Test strip
5803-2 [3022621]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
—
—
—
—
—
—
—
0
12
873
8075
—
Supraventricular tachycardia
I47.1 [45567178]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
—
0
8
877
8118
—
—
—
—
0
14
861
7949
External hemorrhoids without complication
I84.5 [45581832]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
877
8119
—
—
—
—
—
—
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
0
5
877
8121
—
—
—
—
—
Sprain and strain of other and unspecified parts of knee
S83.6 [45579536]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
0
5
877
8121
—
—
—
—
—
rosuvastatin and ezetimibe
C10BA06 [43534777]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
0
5
861
7958
ABO and Rh group [Type] in Blood
882-1 [3003694]
-1.4e-01
1.0e+00
—
—
—
—
1.5e-02
cases:0.57%
controls:0.65%
cases:0.80%
controls:0.28%
—
—
—
—
—
—
—
—
cases:1.05%
controls:1.03%
5
53
872
8073
7
23
870
8103
—
—
—
—
9
82
852
7881
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
—
—
0
20
877
8106
—
—
—
—
—
—
Hypothyroidism caused by autoimmune thyroiditis
E03.80 [2000501406]
—
—
—
—
—
-1.0e+50
-1.0e+50
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.00%
controls:0.14%
—
—
—
—
—
0
5
873
8082
0
11
861
7952
Trigger finger
M65.3 [45538828]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.08%
—
—
—
—
—
—
0
6
861
7957
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 [2000502142]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
0
6
877
8120
—
—
—
—
—
0
5
861
7958
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
5.6e-01
1.1e+00
—
—
—
—
4.4e-01
cases:1.03%
controls:0.59%
cases:0.91%
controls:0.31%
—
—
—
—
—
—
—
—
cases:1.74%
controls:1.13%
9
48
868
8078
8
25
869
8101
—
—
—
—
15
90
846
7873
Shoulder symptom/complaint
L08 [2002000632]
9.1e-01
—
—
—
—
—
8.9e-01
cases:0.91%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
cases:2.09%
controls:0.87%
8
30
869
8096
—
—
—
—
—
18
69
843
7894
Sensorineural hearing loss, unspecified
H90.5 [45547994]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
0
7
861
7956
Gout, unspecified
M10.9 [45543454]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
—
0
6
877
8120
—
—
—
—
—
Predominantly allergic asthma
J45.0 [45557624]
—
—
—
—
—
—
8.4e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.16%
controls:0.50%
—
—
—
—
—
—
10
40
851
7923
testosterone; oral, parenteral, rectal, sublingual, transdermal
G03BA03 [21602510]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.13%
—
—
—
—
—
—
5
10
856
7953
ezetimibe; oral
C10AX09 [21601896]
1.1e+00
1.4e+00
—
—
—
1.0e+00
3.0e-01
cases:0.80%
controls:0.26%
cases:1.03%
controls:0.26%
—
—
—
—
—
—
cases:0.69%
controls:0.25%
cases:0.81%
controls:0.60%
7
21
870
8105
9
21
868
8105
—
—
—
6
20
867
8067
7
48
854
7915
Plastic repair of septum of nose
DJD20 [2001301709]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
877
8121
—
—
—
—
—
—
sucralfate; oral
A02BX02 [21600111]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
877
8119
—
—
—
—
—
—
Other single spontaneous delivery
O80.8 [45534307]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
877
8121
—
—
—
—
—
—
Teeth/gum symptom/complaint
D19 [2002000318]
-7.7e-02
—
—
—
-1.0e+50
—
3.8e-01
cases:0.68%
controls:0.74%
—
—
—
—
—
—
cases:0.00%
controls:0.07%
—
—
cases:2.32%
controls:1.59%
6
60
871
8066
—
—
—
0
6
877
8119
—
20
127
841
7836
cefadroxil; oral
J01DB05 [21602874]
-4.6e-01
—
—
—
—
—
3.2e-01
cases:0.57%
controls:0.90%
—
—
—
—
—
—
—
—
—
—
cases:0.81%
controls:0.59%
5
73
872
8053
—
—
—
—
—
7
47
854
7916
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.14%
0
7
877
8119
—
—
—
—
—
0
11
861
7952
Melanocytic naevi
D22 [45595739]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.09%
0
6
877
8120
—
—
—
—
—
0
7
861
7956
Cellulitis of finger and toe
L03.0 [45557691]
—
—
—
—
—
—
1.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.19%
—
—
—
—
—
—
5
15
856
7948
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
8.1e-02
1.8e-01
9.4e-01
—
4.8e-01
4.5e-01
1.3e-01
cases:4.90%
controls:4.54%
cases:4.22%
controls:3.54%
cases:1.37%
controls:0.54%
—
—
cases:0.91%
controls:0.57%
cases:5.73%
controls:3.75%
cases:9.87%
controls:8.80%
43
369
834
7757
37
288
840
7838
12
44
865
8082
—
8
46
869
8079
50
303
823
7784
85
701
776
7262
Female infertility, unspecified
N97.9 [45582432]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.21%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.15%
0
17
877
8109
—
—
—
—
—
0
12
861
7951
Lactate [Moles/volume] in Arterial blood
2518-9 [3018405]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
9
861
7954
Opening and preparing the root canals, extremely complicated And time consuming
SGA05 [2001310383]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.58%
controls:0.10%
—
—
—
—
—
—
5
8
856
7955
Cerebrovascular disease
K91 [2002000618]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
0
5
861
7958
Emergency procedure
ZXD00 [2001311385]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
—
—
—
—
—
—
0
8
861
7955
Malignant neoplasm of prostate
C61 [45547509]
9.6e-01
8.9e-01
—
—
—
5.1e-01
6.2e-01
cases:0.80%
controls:0.31%
cases:0.68%
controls:0.28%
—
—
—
—
—
—
cases:0.57%
controls:0.35%
cases:0.93%
controls:0.50%
7
25
870
8101
6
23
871
8103
—
—
—
5
28
868
8059
8
40
853
7923
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
-1.9e-01
-2.5e-02
—
—
-1.0e+50
1.1e-01
1.4e-01
cases:1.25%
controls:1.51%
cases:0.91%
controls:0.94%
—
—
—
—
cases:0.00%
controls:0.16%
cases:1.15%
controls:1.03%
cases:3.25%
controls:2.83%
11
123
866
8003
8
76
869
8050
—
—
0
13
877
8112
10
83
863
8004
28
225
833
7738
nifedipine; oral, parenteral
C08CA05 [21601751]
4.7e-01
—
—
—
—
—
7.6e-01
cases:0.68%
controls:0.43%
—
—
—
—
—
—
—
—
—
—
cases:0.70%
controls:0.33%
6
35
871
8091
—
—
—
—
—
6
26
855
7937
Gout
M10 [45533711]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
0
6
877
8120
—
—
—
—
0
5
873
8082
—
Other postsurgical intensive care
WX870 [2001310843]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
877
8121
—
—
—
—
—
—
podophyllotoxin
D06BB04 [21602086]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
0
6
873
8081
—
Positioning and fixed attachment of brackets, extensive
SJC03 [2001310430]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
877
8121
—
—
—
—
—
—
Nausea and vomiting
R11 [45539317]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
0
5
877
8121
—
—
—
—
—
Cat dander IgE Ab [Units/volume] in Serum
6833-8 [3023430]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
0
9
861
7954
losartan; oral
C09CA01 [21601824]
-2.0e-01
-3.3e-01
—
—
-1.0e+50
-3.7e-01
2.1e-02
cases:0.80%
controls:0.97%
cases:0.57%
controls:0.79%
—
—
—
—
cases:0.00%
controls:0.25%
cases:0.69%
controls:0.99%
cases:1.86%
controls:1.82%
7
79
870
8047
5
64
872
8062
—
—
0
20
877
8105
6
80
867
8007
16
145
845
7818
ticagrelor; oral
B01AC24 [40252640]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
—
—
—
—
—
—
0
10
861
7953
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
877
8119
—
—
—
—
—
—

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
505
3329
1.72
21.79
6.5
4.6
1.02
1.02
kg/l
0.75
370
2233
740
5630
1.54
16.72
5.8
4.4
0.00
0.42
estimate
0.59
149
1361
638
4713
1.55
16.41
3.1
2.5
72.69
63.07
u/l
0.52
606
4324
585
4414
1.48
12.89
6.3
4.4
0.00
0.00
estimate
0.78
176
1480
638
4898
1.47
12.87
2.7
2.2
180.62
241.05
u/l
1.37
607
4599
780
6246
1.44
12.49
5.9
4.4
71.50
70.22
ng/l
0.01
637
4965
190
1104
1.81
12.19
7.9
5.9
24.64
24.24
mmol/l
0.85
185
1057
309
2074
1.59
11.54
1.4
1.3
18.27
38.67
iu/ml
6.85
88
642
916
7651
1.40
11.08
5.9
4.3
0.00
2.96
estimate
1.08
184
1721
715
5766
1.40
10.42
3.6
3.4
1529.13
1898.63
ng/l
1.40
637
5055
746
6066
1.39
10.32
5.2
3.8
6.32
6.29
ph
0.39
462
3236
284
1934
1.56
9.86
1.4
1.2
4.58
16.00
u/ml
3.70
110
663
913
7718
1.37
9.77
5.9
4.3
0.00
0.19
estimate
0.53
178
1628
96
487
2.03
9.29
4.8
3.5
3.86
3.95
mmol/l
0.94
96
481
891
7545
1.36
9.22
5.8
4.3
0.00
0.00
estimate
-0.00
178
1663
486
3798
1.38
8.10
3.1
2.8
5.00
5.18
e6/l
0.14
454
3475
1121
9951
1.34
7.91
7.1
5.3
5660.76
1698.64
e6/l
0.49
17
187
1025
8986
1.33
7.85
5.9
5.0
6.84
6.82
mmol/l
0.08
996
8581
392
2975
1.41
7.73
1.7
1.7
1.55
1.57
mg/l
0.03
325
2352
227
1570
1.51
7.26
3.0
2.5
8.19
6.96
ug/l
0.21
203
1345
656
5456
1.32
7.06
4.4
3.6
—
—
—
0
0
240
1693
1.48
6.97
6.5
7.4
122.92
119.45
g/l
1.83
235
1654
475
3799
1.34
6.63
2.9
2.9
353.98
360.76
umol/l
0.66
412
3222
445
3540
1.34
6.41
1.8
1.8
37958535.37
20480663.85
pmol/l
0.26
382
2832
300
2241
1.41
6.39
2.1
1.9
—
—
—
0
0
256
1861
1.44
6.34
6.0
6.9
95.36
95.09
%
0.29
247
1793
204
1431
1.48
6.08
2.4
2.1
0.00
0.02
estimate
0.78
28
267
231
1662
1.45
6.04
1.5
1.4
—
—
—
0
0
241
1757
1.43
5.87
1.8
1.7
—
—
—
0
0
84
480
1.79
5.78
6.3
5.3
1.23
1.39
mmol/l
1.28
79
420
29
110
2.66
5.58
1.3
1.5
25.64
27.61
%
0.11
18
67
897
7928
1.26
5.58
21.7
20.0
1.36
1.38
inr
0.50
803
6718
905
8028
1.26
5.38
6.5
6.6
10.68
12.78
umol/l
7.96
881
7630
77
439
1.79
5.36
17.2
12.3
—
—
—
0
0
274
2088
1.37
5.14
6.0
6.7
7.42
7.42
ph
0.34
184
1147
195
1403
1.44
5.10
2.8
2.4
0.51
0.55
e6/l
0.13
190
1347
767
6714
1.25
4.99
3.4
2.9
—
—
estimate
—
0
0
102
642
1.62
4.97
1.5
1.3
—
—
—
0
0
271
2101
1.34
4.53
6.1
6.6
5.04
5.07
kpa
0.17
262
2008
270
2102
1.34
4.39
6.1
6.6
11.17
11.85
kpa
1.80
261
2009
267
2083
1.33
4.28
6.2
6.6
1.07
0.99
mmol/l
0.11
219
1694
833
7441
1.22
4.26
6.4
6.3
1.20
1.21
mmol/l
2.96
783
6798
588
5067
1.24
4.24
4.5
4.4
—
—
—
0
0
406
3364
1.27
4.12
1.8
1.8
1217.54
1190.16
nmol/l
0.23
331
2497
207
1567
1.36
4.05
1.3
1.3
392.17
552.61
titre
1.20
46
352
160
1173
1.40
3.81
3.4
3.0
5.93
6.04
ph
0.97
120
853
284
2278
1.29
3.71
4.4
5.1
1.04
1.04
mmol/l
0.09
266
2088
8
12
6.69
3.67
1.9
3.1
0.75
0.83
u/field
—
8
12
330
2705
1.27
3.63
3.2
3.0
0.81
0.82
mmol/l
0.61
304
2524
322
2636
1.27
3.58
1.3
1.2
1.01
1.92
u/ml
1.71
86
660
803
7229
1.20
3.58
5.9
5.7
0.04
0.04
e9/l
0.18
727
6033
29
137
2.14
3.56
1.2
1.2
126106.00
122434.20
e6/l
0.01
19
89
69
431
1.63
3.55
1.5
1.4
249.17
273.28
ug/g
0.44
38
255
73
463
1.60
3.53
1.6
1.7
8.79
8.11
iu/ml
0.06
19
110
94
634
1.51
3.48
1.4
1.3
71.60
64.33
au/ml
—
7
50
133
960
1.42
3.48
2.5
2.5
1.26
1.10
%
0.98
133
952
132
952
1.42
3.47
2.5
2.5
0.60
0.61
%
0.18
132
945
151
1117
1.38
3.43
3.7
3.7
5.22
5.18
kpa
0.23
145
1063
185
1416
1.34
3.39
2.4
2.2
167.46
144.83
ug/g
0.43
144
1119
452
3870
1.22
3.35
4.7
3.9
0.00
0.06
estimate
1.36
151
1263
1097
10200
1.19
3.31
5.1
4.3
15.20
15.16
pmol/l
0.21
1025
9094
797
7210
1.19
3.27
5.9
5.7
0.59
0.62
e9/l
2.04
721
6007
618
5470
1.20
3.23
4.8
4.1
—
0.68
—
0
19
213
1676
1.31
3.22
3.5
3.2
4.33
4.95
e9/l
0.89
193
1402
341
2844
1.25
3.22
5.8
4.6
—
—
—
0
0
818
7424
1.19
3.22
6.0
5.9
0.19
0.19
e9/l
0.55
750
6290
892
8172
1.18
3.10
9.0
9.1
4.30
4.33
e9/l
0.11
806
6983
808
7343
1.18
3.09
6.0
5.8
1.82
1.81
e9/l
0.05
745
6290
146
1095
1.36
3.07
3.8
3.7
7.42
7.41
ph
0.13
119
915
798
7270
1.18
2.90
4.9
5.0
34.61
34.47
g/l
0.33
754
6756
100
710
1.43
2.90
2.7
2.5
18.65
19.80
au/ml
0.05
11
51
1184
11150
1.18
2.85
9.1
8.2
80.12
83.53
u/l
1.39
1135
10465
496
4350
1.19
2.81
6.8
6.4
—
—
—
0
0
382
3279
1.21
2.72
5.3
4.2
231.39
344.93
ng/l
0.37
308
2853
101
730
1.41
2.68
3.3
3.4
4.21
4.36
pmol/l
0.83
90
642
895
8272
1.16
2.62
7.4
7.0
1.21
1.21
mmol/l
1.63
790
7039
633
5695
1.17
2.62
3.0
3.5
2.35
2.35
mmol/l
0.47
588
5108
190
1517
1.28
2.60
1.4
1.3
—
—
—
0
0
338
3936
0.83
2.58
3.9
4.1
87.56
84.02
%
1.85
333
3844
97
702
1.40
2.57
2.3
2.1
0.04
0.01
estimate
0.40
25
198
12
44
2.74
2.55
1.3
1.2
141.25
161.11
mmol/24h
0.26
12
44
501
4434
1.18
2.52
3.3
3.1
37.45
38.03
u/l
0.04
473
4160
870
8041
1.16
2.51
3.7
3.3
52.43
55.84
u/l
0.46
827
7327
145
1124
1.32
2.49
6.2
8.5
0.64
0.63
%
0.09
145
1116
18
82
2.21
2.47
1.1
1.1
0.21
5.18
nmol/l
—
5
15
192
1554
1.26
2.37
4.0
4.4
7.31
7.36
ph
1.19
150
1075
149
1168
1.30
2.37
6.3
8.4
93.75
93.61
%
0.17
149
1159
173
1389
1.27
2.29
4.6
4.0
1.13
0.90
%
0.49
71
461
27
148
1.84
2.29
1.3
1.6
54.06
65.31
%
0.70
17
95
101
752
1.36
2.29
4.1
3.8
—
—
—
0
0
235
1955
1.23
2.28
1.2
1.3
—
—
—
0
0
21
106
1.99
2.26
1.5
1.6
97.48
101.32
ng/l
0.09
21
106
149
1177
1.29
2.24
6.3
8.2
1.40
1.29
%
0.75
149
1166
568
5121
1.16
2.23
4.0
4.1
7.40
7.40
ph
0.46
453
3674
598
5414
1.16
2.22
3.8
3.6
130.77
82.79
e6/l
0.22
501
4210
107
814
1.33
2.12
2.0
1.8
1.21
2.23
ug/l
0.70
94
701
21
109
1.94
2.10
1.0
1.3
—
—
—
0
0
18
89
2.03
2.06
1.1
1.7
70.46
5658.44
u/l
—
5
30
37
230
1.62
2.06
2.5
2.4
—
—
—
0
0
651
5956
1.15
2.05
4.3
4.2
152.68
129.19
e6/l
0.17
500
4338
690
6357
1.14
1.94
3.3
3.0
136.98
147.88
ug/l
0.50
649
5781
230
2702
0.83
1.92
3.4
3.3
2.92
2.41
e6/l
0.34
126
1374
54
374
1.46
1.88
3.8
3.3
1665.57
1218.77
u/ml
0.11
48
343
17
86
1.99
1.85
2.4
2.6
8.38
7.30
mmol/l
0.37
12
54
1372
13242
1.15
1.83
24.8
19.3
26.85
28.55
mg/l
1.07
1229
11265
332
2917
1.17
1.80
2.5
2.6
11.75
11.77
umol/l
0.02
308
2702
7
167
0.42
1.79
1.0
1.2
—
—
—
0
0
160
1315
1.24
1.78
4.6
4.1
0.17
0.11
%
0.54
58
389
26
154
1.70
1.76
1.9
2.2
—
—
—
0
0
578
5297
1.13
1.73
4.1
4.0
6.97
8.42
mg/mmol
0.35
398
3285
7
24
2.92
1.72
1.0
1.2
—
—
—
0
0
5
13
3.85
1.71
1.2
1.2
—
—
—
0
0
5
13
3.85
1.71
1.4
1.3
59.40
68.15
ug/l
—
5
13
159
1312
1.23
1.71
4.5
4.0
0.92
0.78
%
0.21
64
429
15
281
0.53
1.70
1.2
1.8
—
—
—
0
0
40
267
1.51
1.69
1.0
1.0
—
—
—
0
0
570
5227
1.13
1.68
3.5
3.3
6.97
6.96
mmol/l
0.01
492
4317
152
1254
1.23
1.65
2.4
2.2
405.10
395.80
nmol/l
0.18
139
1151
45
310
1.46
1.64
1.8
1.8
4.98
22.90
iu/l
0.47
14
125
356
3978
0.87
1.60
3.4
3.5
—
—
—
0
0
19
106
1.80
1.59
1.1
1.1
0.45
1.29
u/ml
0.97
11
53
582
6296
0.89
1.58
14.4
12.2
0.00
0.00
e9/l
0.42
508
5048
185
1565
1.20
1.57
3.8
3.1
217.84
258.41
ng/l
0.71
167
1441
501
4578
1.13
1.55
2.8
2.3
3.16
2.96
mg/l
1.12
445
3888
203
1736
1.19
1.54
2.9
2.5
71.05
68.11
e9/l
0.46
177
1272
19
108
1.77
1.50
1.3
1.2
0.44
0.45
g/l
0.03
14
80
19
108
1.77
1.50
1.3
1.2
7.13
7.50
g/l
0.22
14
80
19
108
1.77
1.50
1.3
1.2
3.28
2.84
g/l
0.33
14
81
6
21
2.86
1.50
1.2
1.1
—
—
—
0
0
13
65
2.01
1.48
1.1
1.2
159.08
135.15
nmol/l
0.41
13
65
289
2559
1.15
1.43
2.0
2.0
30.35
29.84
s
0.63
275
2479
20
118
1.70
1.41
2.8
3.5
22.29
26.46
mg/l
0.14
15
95
272
3069
0.87
1.41
3.1
3.5
0.79
0.84
ug/l
0.32
204
2201
19
111
1.72
1.39
1.6
1.8
1033.74
1016.99
e6/l
0.03
19
99
12
224
0.53
1.38
1.3
1.4
5.27
6.55
mmol/l
1.53
12
215
305
2723
1.14
1.35
2.4
2.5
2.34
2.25
g/l
2.41
281
2501
66
505
1.32
1.35
1.2
1.2
—
—
—
0
0
113
926
1.24
1.34
1.2
1.2
—
—
—
0
0
546
5055
1.12
1.34
1.8
1.8
19.15
20.12
nmol/l
0.75
475
4220
92
737
1.26
1.33
2.1
2.0
—
—
—
0
0
17
98
1.74
1.31
1.3
1.7
—
—
—
0
0
124
1480
0.83
1.27
2.9
2.3
39.47
35.71
u/l
0.20
104
1226
155
1319
1.19
1.27
4.8
4.4
0.27
0.10
%
0.41
52
365
133
1118
1.20
1.25
3.0
2.9
126.57
126.39
g/l
0.03
126
1089
262
2329
1.15
1.24
1.5
1.4
2.58
2.74
g/l
0.50
157
1320
6
25
2.40
1.24
1.0
1.0
—
—
—
0
0
183
1584
1.17
1.24
1.7
2.5
66.81
65.81
g/l
0.96
167
1433
13
70
1.86
1.24
2.2
2.6
543.54
1508.73
u/ml
1.85
13
70
285
2550
1.14
1.23
2.4
2.6
20.38
21.36
%
0.68
263
2357
699
6580
1.10
1.23
2.5
2.4
80.10
79.82
nmol/l
0.09
640
5755
49
365
1.35
1.22
1.6
1.4
13127.54
18385.89
e6/l
0.49
37
246
145
1234
1.19
1.20
1.4
1.5
—
—
—
0
0
18
109
1.66
1.19
1.3
1.2
—
—
—
0
0
89
724
1.24
1.16
2.3
2.7
—
—
—
0
0
15
87
1.73
1.15
1.7
1.7
74.13
70.90
%
0.53
15
80
553
5161
1.10
1.15
3.5
3.4
35.47
46.31
mg/l
0.70
401
3323
488
5249
0.90
1.15
2.0
1.9
1.42
1.29
mmol/l
2.24
416
4283
22
142
1.56
1.14
1.1
1.3
—
—
—
0
0
1021
10607
0.91
1.14
26.1
24.1
14.00
13.95
%
0.57
1005
10433
531
4957
1.10
1.09
2.6
2.6
—
—
—
0
0
22
144
1.53
1.08
1.1
1.3
—
—
nmol/l
—
0
0
11
193
0.57
1.07
1.8
1.8
—
—
—
0
0
26
178
1.47
1.05
1.2
1.3
0.62
10.78
nmol/l
0.50
26
168
158
1373
1.17
1.05
1.5
1.5
—
—
—
0
0
500
4664
1.10
1.04
3.6
3.5
0.49
0.53
e6/l
0.15
413
3506
202
1789
1.15
1.04
3.0
3.4
2.14
1.80
mmol/l
0.70
174
1530
180
2042
0.87
1.04
1.3
1.4
—
—
—
0
0
22
146
1.51
1.03
1.8
2.2
2.21
1.16
u/field
0.32
14
75
13
75
1.74
1.02
1.6
1.6
54.00
117.01
e6/l
1.72
13
70
28
196
1.44
1.02
1.4
1.5
—
—
—
0
0
28
196
1.44
1.02
1.4
1.5
—
—
—
0
0
28
196
1.44
1.02
1.4
1.5
—
—
—
0
0
28
196
1.44
1.02
1.4
1.5
—
—
—
0
0
9
47
1.92
1.02
1.9
1.4
32.33
29.09
%
—
9
47
36
265
1.37
1.00
1.2
1.2
8.00
32.77
e6/l
0.57
30
202
120
1397
0.85
0.98
1.5
1.4
—
—
—
0
0
0
31
0.00
0.96
0.0
1.5
—
—
—
0
0
0
31
0.00
0.96
0.0
1.5
—
1.28
—
0
22
0
31
0.00
0.96
0.0
1.3
—
49.54
—
0
23
0
32
0.00
0.95
0.0
1.7
—
—
—
0
0
67
543
1.24
0.94
2.5
3.1
244.33
364.55
mg/l
0.44
24
228
25
175
1.43
0.93
1.2
1.3
163.56
173.61
miu/ml
—
7
57
207
1853
1.13
0.92
3.2
3.4
7.38
7.38
ph
0.76
114
1105
12
70
1.72
0.92
1.9
2.2
218.83
210.65
e6/l
0.06
12
62
99
839
1.19
0.91
1.2
1.3
—
—
—
0
0
207
1856
1.13
0.90
3.0
3.4
5.87
5.80
kpa
0.47
202
1805
34
451
0.75
0.90
4.5
4.7
—
—
—
0
0
127
1100
1.17
0.90
1.4
1.6
—
—
—
0
0
1286
12547
1.09
0.89
8.1
7.0
41.01
40.18
mmol/mol
2.69
1213
11453
7
129
0.54
0.88
1.1
1.3
—
—
—
0
0
17
111
1.54
0.87
1.0
1.0
250.56
293.93
ng/l
—
9
70
1069
10357
1.08
0.87
31.1
25.7
330.79
330.68
g/l
0.15
1062
10271
17
112
1.52
0.85
1.0
1.0
721.63
616.62
ng/l
—
8
69
62
510
1.22
0.79
4.2
3.4
0.76
0.82
nmol/l
0.90
55
417
27
362
0.74
0.79
1.3
1.2
—
—
—
0
0
17
114
1.50
0.79
1.4
1.1
99.35
100.77
pmol/l
0.04
17
114
407
3810
1.09
0.79
3.6
3.4
0.00
0.05
—
6
130
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
17
246
0.69
0.78
1.4
1.6
—
—
—
0
0
1258
12290
1.08
0.78
6.3
5.4
1.95
2.06
mu/l
2.22
1179
11058
66
548
1.21
0.78
1.3
1.3
—
—
—
0
0
26
192
1.36
0.75
1.1
1.2
—
—
—
0
0
36
459
0.78
0.75
3.7
3.7
0.68
1.92
index
2.44
19
242
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
19
135
1.41
0.69
1.2
1.2
—
86.60
—
0
8
24
178
1.35
0.69
1.4
1.2
8.08
10.28
u/l
0.53
17
141
122
1082
1.14
0.67
1.4
1.5
—
—
—
0
0
7
43
1.63
0.67
2.1
1.3
—
—
—
0
0
29
223
1.31
0.66
1.7
1.8
18.60
19.61
ug/l
0.11
29
218
30
232
1.30
0.66
1.8
1.9
6.33
4.68
mmol/24h
1.22
25
197
80
691
1.17
0.64
1.3
1.2
—
—
—
0
0
763
7363
1.06
0.64
2.3
2.3
95.71
93.58
pmol/l
0.55
427
3845
49
405
1.22
0.63
3.0
4.1
—
—
—
0
0
169
1536
1.11
0.63
5.0
7.6
—
—
—
0
0
12
80
1.50
0.59
1.2
1.1
—
—
—
0
0
42
346
1.22
0.57
1.8
2.2
43.03
77.55
ug/min
0.80
26
204
6
35
1.72
0.57
1.3
2.7
26.68
252.13
ug/l
—
6
30
43
517
0.83
0.57
1.6
1.9
21.11
21.31
s
0.11
38
473
697
6728
1.06
0.57
6.3
6.0
8.96
9.14
%
0.56
656
6237
27
341
0.79
0.56
1.4
1.4
—
—
—
0
0
6
37
1.62
0.55
1.5
2.2
9.33
9.53
%
—
6
32
50
422
1.19
0.54
1.2
1.5
—
—
—
0
0
1223
12002
1.06
0.54
5.0
4.4
1.33
1.25
mmol/l
3.79
1142
10649
11
159
0.69
0.54
1.0
1.1
1.60
1.61
g/l
0.02
11
143
81
918
0.88
0.53
2.0
1.8
1.54
1.55
g/l
0.01
70
792
45
377
1.20
0.53
1.4
1.2
—
—
—
0
0
6
97
0.62
0.52
1.2
1.8
—
—
—
0
0
9
64
1.41
0.51
1.3
1.5
9.13
11.02
ug/l
—
9
57
9
65
1.39
0.50
1.1
1.0
—
—
—
0
0
173
1600
1.09
0.49
2.4
2.1
0.20
0.20
g/l
0.54
167
1477
15
110
1.37
0.48
1.2
1.1
—
—
—
0
0
30
366
0.82
0.48
4.5
3.8
29.88
30.57
mg/l
0.03
23
269
693
6717
1.05
0.48
6.2
5.9
2.67
2.75
%
0.51
652
6225
12
85
1.41
0.47
1.2
1.1
—
—
—
0
0
15
111
1.35
0.46
1.2
1.1
—
—
—
0
0
59
675
0.87
0.46
1.3
2.4
10.30
10.61
g/l
0.16
49
586
8
117
0.68
0.46
1.1
1.3
—
—
—
0
0
51
440
1.16
0.45
1.5
1.4
—
—
—
0
0
59
673
0.87
0.45
3.0
3.3
1622.45
6269.28
u/ml
0.54
52
575
21
165
1.28
0.45
1.8
1.6
40.47
32.98
ng/l
0.17
21
165
580
5605
1.05
0.45
2.2
2.3
—
—
—
0
0
239
2249
1.07
0.45
2.5
2.4
1.97
1.81
%
1.08
218
1983
692
6717
1.05
0.45
6.4
6.0
0.66
0.65
%
0.28
654
6226
167
1796
0.92
0.44
5.6
5.2
33.05
33.85
%
0.49
126
1108
9
128
0.70
0.43
1.1
1.3
—
—
—
0
0
9
131
0.69
0.43
1.1
1.3
—
—
—
0
0
9
131
0.69
0.43
1.1
1.3
—
—
—
0
0
27
328
0.82
0.43
1.4
1.5
34.86
30.29
g/l
1.04
22
299
702
6823
1.05
0.43
6.3
6.0
26.42
25.34
%
1.83
671
6409
343
3593
0.94
0.43
1.4
1.3
—
—
—
0
0
15
196
0.76
0.43
2.1
1.3
—
—
—
0
0
30
249
1.21
0.41
3.1
2.6
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
229.92
—
0
11
0
17
0.00
0.40
0.0
1.0
—
16.50
—
0
10
0
17
0.00
0.40
0.0
3.5
—
61.33
—
0
7
43
371
1.16
0.40
3.3
4.7
2.37
2.85
mmol/l
0.61
29
244
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
7
104
0.67
0.39
1.9
2.2
—
—
—
0
0
5
35
1.43
0.39
1.4
1.6
—
3474.29
—
0
7
43
372
1.16
0.39
3.3
4.7
4.93
5.06
kpa
0.65
43
365
43
372
1.16
0.39
3.3
4.7
8.44
8.19
kpa
0.46
43
365
171
1602
1.07
0.38
5.3
6.1
10.83
11.35
mmol/l
0.39
161
1522
24
197
1.22
0.37
1.1
1.2
250.45
287.02
u/ml
0.22
11
101
9
69
1.31
0.37
1.2
1.1
33.86
40.39
mg/l
—
9
57
8
114
0.70
0.37
2.3
2.5
—
—
—
0
0
9
70
1.29
0.36
1.7
1.4
—
—
—
0
0
54
607
0.89
0.35
2.0
3.2
3.67
3.70
ratio
0.01
36
360
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
44
501
0.88
0.35
1.6
1.8
3.39
3.42
mmol/l
0.06
31
373
683
6661
1.04
0.35
6.2
5.9
58.38
59.18
%
0.98
656
6309
9
123
0.73
0.35
1.1
1.3
—
—
—
0
0
10
73
1.37
0.34
1.3
2.0
581.30
549.20
e6/l
—
10
60
112
1038
1.08
0.34
2.9
3.4
24.58
24.05
mmol/l
1.10
112
1023
6
45
1.33
0.33
1.0
1.0
1303.33
1746.84
miu/ml
—
6
45
21
253
0.83
0.33
1.7
1.5
119.05
284.10
pmol/l
2.01
21
248
1398
13842
1.05
0.32
29.3
23.7
139.51
139.56
mmol/l
0.25
1379
13518
30
257
1.17
0.32
1.2
1.2
—
—
—
0
0
1301
12868
1.04
0.31
6.2
5.6
6.15
6.06
mmol/l
1.54
1216
11421
19
156
1.22
0.31
1.3
1.4
16.21
13.87
u/l
0.55
19
149
8
107
0.75
0.29
1.1
1.1
—
—
—
0
0
148
1398
1.06
0.28
4.1
3.7
1.22
1.22
mmol/l
0.05
140
1179
1398
13856
1.04
0.28
29.3
23.9
4.00
4.00
mmol/l
0.08
1376
13516
11
85
1.30
0.28
1.3
1.2
0.08
0.78
u/ml
—
6
46
8
65
1.23
0.27
1.1
1.1
271.50
249.53
mg/l
—
8
57
8
65
1.23
0.27
1.4
1.4
28.63
22.88
%
—
8
59
24
279
0.86
0.27
1.5
1.4
1134.84
4755.83
e6/l
0.55
19
183
23
196
1.18
0.27
1.7
1.7
1.14
0.92
g/l
0.21
17
157
103
1100
0.93
0.26
5.5
7.2
24.19
24.78
mmol/l
0.84
103
1093
11
86
1.28
0.26
1.3
1.4
1.07
1.04
promille
—
6
66
32
361
0.88
0.25
1.2
1.4
63.32
59.34
mmol/l
0.22
22
294
20
170
1.18
0.24
1.2
1.2
1.62
1.57
g/l
0.32
20
170
5
38
1.32
0.23
2.8
2.0
—
—
—
0
0
35
314
1.12
0.22
4.7
3.1
57.86
59.83
%
0.29
35
314
163
1703
0.95
0.22
3.0
2.6
8.23
10.49
umol/l
0.93
144
1496
108
1021
1.06
0.22
3.2
2.9
11.26
11.01
g/l
0.12
102
917
62
574
1.08
0.22
3.2
3.9
7.41
7.41
ph
0.29
62
567
22
191
1.15
0.22
1.2
1.3
0.83
0.93
g/l
0.91
22
191
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
2.6
—
45.74
—
0
5
48
440
1.09
0.21
2.8
2.3
124.78
125.47
g/l
0.08
41
354
1261
12503
1.03
0.21
5.7
5.2
1.42
1.46
mmol/l
2.63
1179
11230
78
731
1.07
0.21
1.3
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
17
145
1.17
0.20
1.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
100.57
—
0
14
16
187
0.85
0.20
1.3
1.0
—
—
—
0
0
13
155
0.84
0.20
1.5
1.1
—
—
—
0
0
6
49
1.23
0.20
1.5
1.1
—
—
—
0
0
62
665
0.93
0.20
2.0
3.4
65.95
140.10
mg/l
0.43
50
568
62
665
0.93
0.20
1.9
3.4
37.60
57.87
mg/l
1.34
51
571
1386
13767
1.03
0.19
14.6
12.7
23.69
24.22
u/l
0.68
1354
13222
11
90
1.22
0.19
1.4
1.7
71.73
87.98
umol/l
2.07
11
90
15
128
1.17
0.18
1.3
1.4
—
—
—
0
0
27
242
1.12
0.18
1.1
1.2
—
—
—
0
0
32
290
1.11
0.18
2.7
2.0
0.85
0.86
%
0.04
25
206
29
320
0.90
0.17
1.1
1.2
—
—
—
0
0
11
131
0.84
0.17
1.1
1.1
—
—
—
0
0
514
5053
1.02
0.17
6.1
5.6
—
—
—
0
0
1273
12644
1.02
0.16
5.9
5.2
4.41
4.44
mmol/l
0.53
1204
11448
8
70
1.14
0.16
1.8
1.9
0.73
0.58
e9/l
—
8
65
297
2900
1.03
0.16
3.1
3.1
1.70
1.33
e6/l
0.44
189
1579
8
73
1.10
0.15
1.0
1.6
4.42
22.48
umol/l
—
8
47
6
80
0.75
0.15
1.0
1.0
245.83
295.06
mg/l
—
6
66
324
3310
0.97
0.15
3.2
3.1
531.52
532.36
mosm/kgh2o
0.02
294
2907
12
102
1.18
0.15
2.2
2.3
—
35.82
—
0
18
85
811
1.05
0.14
1.7
1.8
1.06
1.43
g/l
1.74
79
717
22
244
0.90
0.14
1.2
1.5
—
—
—
0
0
45
422
1.07
0.13
1.7
1.6
9.30
23.54
u/ml
—
6
67
41
384
1.07
0.12
1.8
1.6
0.17
0.33
mg/l
2.17
21
160
96
925
1.04
0.12
2.3
2.3
12.45
12.34
nmol/l
0.05
85
814
13
114
1.14
0.11
1.7
2.5
17.39
16.24
%
0.71
13
114
1291
12969
0.98
0.10
6.7
6.1
2.52
2.54
mmol/l
0.28
1207
11691
521
5270
0.98
0.10
6.1
6.0
3.29
4.87
ug/l
0.97
476
4672
90
872
1.03
0.09
2.7
2.4
—
—
—
0
0
6
54
1.11
0.09
1.0
1.3
—
—
—
0
0
42
441
0.95
0.09
2.0
3.6
—
—
—
0
0
6
57
1.05
0.08
1.0
1.0
—
—
—
0
0
13
144
0.90
0.08
1.0
1.2
6.83
7.97
u/ml
—
6
66
68
657
1.04
0.08
1.2
1.2
95.61
135.35
u/ml
0.57
30
242
7
65
1.08
0.08
1.1
1.3
—
—
—
0
0
7
68
1.03
0.07
1.0
1.7
43.97
39.34
g/l
—
7
68
1328
13323
0.99
0.07
23.1
17.6
—
—
—
0
0
21
225
0.93
0.07
1.2
1.4
—
—
—
0
0
1407
14031
1.01
0.07
31.7
26.0
83.56
83.95
umol/l
0.14
1390
13792
364
3603
1.01
0.07
3.0
3.1
2.47
2.47
mmol/l
0.00
323
3243
9
100
0.90
0.06
1.4
1.1
—
—
—
0
0
88
859
1.03
0.06
3.8
3.8
1.02
1.02
ratio
0.66
82
783
20
213
0.94
0.06
1.1
1.2
—
—
—
0
0
24
227
1.06
0.06
1.2
1.3
—
—
—
0
0
116
1181
0.98
0.05
1.5
1.5
—
—
—
0
0
188
1899
0.99
0.04
4.1
4.2
33.06
23.72
ug/l
0.13
167
1578
1411
14130
0.99
0.03
36.7
29.4
131.44
131.16
g/l
0.29
1391
13892
13
122
1.07
0.02
1.3
1.2
—
—
—
0
0
1411
14127
0.99
0.02
36.4
29.1
4.36
4.35
e12/l
0.20
1376
13686
1411
14127
0.99
0.02
36.2
29.0
30.40
30.43
pg
0.28
1395
13885
1411
14127
0.99
0.02
36.8
29.6
39.58
39.23
%
1.75
1392
13876
1411
14126
0.99
0.02
36.3
29.0
91.88
91.88
fl
0.02
1396
13885
1411
14125
0.99
0.02
36.4
29.1
243.79
241.97
e9/l
0.46
1385
13742
23
222
1.04
0.02
17.0
6.1
7.44
7.35
mmol/l
0.04
18
194
12
113
1.06
0.01
1.0
1.2
—
—
—
0
0
12
113
1.06
0.01
2.6
2.6
13.86
33.90
mg/l
—
7
84
17
177
0.96
0.01
1.1
1.3
15.82
11.14
u/l
0.67
17
164
11
104
1.06
0.01
3.4
3.1
—
—
—
0
0
10
99
1.01
0.00
1.0
1.4
—
—
—
0
0
12
121
0.99
0.00
1.6
2.2
7.60
8.55
mmol/l
0.75
12
121
26
255
1.02
0.00
1.4
1.4
18307.00
64534.04
e6/l
0.96
18
136
17
171
0.99
0.00
1.2
1.2
—
—
—
0
0
18
181
0.99
0.00
1.5
2.0
—
—
—
0
0
10
96
1.04
0.00
1.1
1.2
12.02
10.22
mmol/l
—
10
91
119
1191
1.00
0.00
6.6
4.4
—
—
—
0
0
136
1361
1.00
0.00
3.5
3.5
100.81
97.86
ng/l
0.09
117
1131
31
312
0.99
0.00
1.2
1.2
18.31
42.04
u/l
2.05
26
265
17
168
1.01
0.00
2.2
2.9
—
—
—
0
0
1413
14128
1.00
0.00
36.5
29.1
6.94
6.93
e9/l
0.05
1377
13684
13
133
0.98
0.00
1.2
1.2
—
—
—
0
0
13
127
1.02
0.00
1.1
1.1
—
—
—
0
0
15
153
0.98
0.00
1.1
1.2
0.60
0.74
ratio
—
5
29
17
173
0.98
0.00
1.0
1.1
10.20
83.64
iu/ml
—
5
29
18
177
1.02
0.00
1.3
1.1
—
—
—
0
0
20
197
1.02
0.00
2.4
2.2
0.52
1.45
g/24h
1.75
11
112
36
357
1.01
0.00
1.1
1.1
—
—
—
0
0
5
56
0.89
-0.00
1.2
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
4.5
—
12.67
—
0
6
0
8
0.00
-0.00
0.0
3.8
—
—
—
0
0
9
90
1.00
-0.00
1.4
1.2
1.81
2.05
mmol/l
—
9
82
5
54
0.93
-0.00
1.4
1.2
81.26
167.33
pmol/l
—
5
54
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
363.60
—
0
5
8
82
0.98
-0.00
1.9
1.6
15.49
13.90
umol/l
—
8
76
7
74
0.95
-0.00
1.3
1.5
0.57
1.68
%
—
7
63
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
68
0.88
-0.00
6.5
4.0
—
—
—
0
0
5
56
0.89
-0.00
1.2
1.1
—
—
—
0
0
5
49
1.02
-0.00
1.0
1.1
0.66
0.47
ratio
—
5
29
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
7
76
0.92
-0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
9.10
—
0
6
0
5
0.00
-0.00
0.0
2.6
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint G6_SCIALE and mortality.

Females

Parameter HR [95% CI] p-value
G6_SCIALE 1.172 [0.97, 1.42] 0.101
Birth year 0.997 [0.99, 1.01] 0.488

During the follow-up period (1.1.1998 — 31.12.2019), 163 out of 1132 females with G6_SCIALE died.

Males

Parameter HR [95% CI] p-value
G6_SCIALE 1.186 [0.97, 1.45] 0.102
Birth year 0.991 [0.98, 1.0] 0.046

During the follow-up period (1.1.1998 — 31.12.2019), 132 out of 704 males with G6_SCIALE died.

Mortality risk

Mortality risk for people of age

years, who have G6_SCIALE.

N-year risk Females Males
1 0.119% 0.265%
5 0.738% 1.466%
10 1.822% 3.853%
15 3.507% 7.224%
20 6.276% 12.375%

Relationships between endpoints

↥

Index endpoint: G6_SCIALE – Lesion of sciatic nerve

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data